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Human bocavirus is a human pathogen that was identified in 2005. For the past decade, 
most of the studies about this virus were focused on clinical detection and its association-with 
diseases, while very little was known about the molecular virology.  
The studies presented in this thesis are composed of three parts: 1) Identification of 
novel HBoV1 proteins by transfection of an HBoV1 infectious clone or during HBoV1 infection; 
2) exploring the interactions between the viral genome and proteins to uncover the details 
underlying HBoV DNA replication; and 3) providing evidence of HBoV1 hairpin independent 
DNA replication. 
In the first study, we identified three new non-structural proteins of human bocavirus 1 
during infection of polarized human airway epithelium. Of the three newly identified proteins, we 
proved that one non-structural protein is critical for virus replication in the polarized human 
bronchial airway epithelium. The creation of a non-replicating infectious HBoV1 mutant may 
have particular utility in vaccine development for this virus.      
In the second study, we identified both cis- and trans-acting proteins that are required for 
HBoV1 DNA replication at the right-end hairpin in HEK293 cells. We also localized the minimal 
replication origin to a 46-nt sequence in the right-end hairpin, which contains both NS1 nicking 
and binding sites. The identification of these essential elements of HBoV1 DNA replication 
acting both in cis and trans provides opportunities for developing antiviral strategies targeting 
HBoV1 DNA replication, and to design next generation recombinant HBoV1 vectors, a 
promising tool for gene therapy of lung diseases. 
In the third study, we provided evidence that HBoV1 could replicate independent of 
hairpin sequence, which is quite different from other parvoviruses. Although the mechanisms 
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                                                                    Chapter 1 
 
Introduction 
After the isolation of bovine parvovirus (BPV) in 1961, only canine minute virus (or 
minute virus of canines, MVC) was classified in the genus Bocavirus of the Parvoviridae family, 
until the discovery of human bocavirus 1 (HBoV1) in 2005 (1,3,28). Since then, more viruses 
were isolated and classified in the genus Bocavirus, including porcine bocavirus, gorilla 
bocavirus, feline bocavirus and sea lion bocavirus (18,77,86,91). In 2014, the International 
Committee on Taxonomy of Viruses (ICTV) reclassified the Parvoviridae family (28). All 
bocaviruses are now in the genus Bocaparvovirus.  
Parvovirus is a non-enveloped icosahedral virus with linear single-stranded DNA 
(ssDNA) genome in a size range of ~4.7-5.7 kilobases (kb) (28). There are two subfamilies in 
the Parvoviridae family, which are Parvovirinae and Densovirinae. The former subfamily of 
viruses infect vertebrates, while the latter infect invertebrates. Eight genera are included within 
the Parvovirinae subfamily in the most updated classification, including Amdoparvovirus, 
Aveparvovirus, Bocaparvovirus, Copiparvovirus, Dependoparvovirus, Erythroparvovirus, 
Protoparvovirus and tetraparvovirus (28). Adeno-associated virus (AAV) in the genus 
Dependoparvovirus, parvovirus B19 in the genus Erythroparvovirus, and minute virus of mice 
(MVM) in the genus Protoparvovirus have been well studied. Both termini of their genomes 
contain partial double-stranded hairpin structures with mismatched nucleotides.  
The terminal hairpin structures are critical to parvovirus replication.  Parvoviruses that 
have unique terminal hairpin sequence are called heterotelomeric parvoviruses, while 
parvoviruses that have identical hairpin terminal sequence are called homotelomeric 
parvoviruses. The two terminal repeats of heterotelmoeric parvoviruses, e.g., MVM and MVC, 
are named the left-end hairpin (LEH) and the right-end hairpin (REH), which correspond to the 
3’ end and 5’ end of the negative sense ssDNA viral genome, respectively. For homotelomeric 
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parvoviruses, e.g., AAV and B19, the terminal hairpins are called inverted terminal repeats 
(ITRs). Based on whether parvovirus replication relies on another helper virus, e,g., adenovirus, 
parvoviruses are referred as dependoparvovirus (AAV) or autonomous parvovirus (e.g., B19, 
MVM, and MVC).  
  This introduction summarizes the epidemiology, genome organization, transcription 
profile, functions of viral proteins, and infection life cycle of HBoV1 with discussions of other 
bocaparvoviruses. Additionally, the general models and mechanisms of parvovirus DNA 
replication are discussed.  
Epidemiology of HBoV1  
To date, four species of human bocaparvoviruses have been isolated. They are HBoV1, 
HBoV2, HBoV3, and HBoV4 in the order of their discovery. HBoV1 was first identified from 
nasopharyngeal aspirates of young children who had lower respiratory tract infections (3). It was 
also detected in blood and stool samples (154), whereas HBoV2, HBoV3 and HBoV4 were 
mainly found in stool samples (5,78,79). HBoV1 is found globally and associated with acute 
respiratory infections, such as acute wheezing, pneumonia, asthma, or bronchiolitis, especially, 
in infants under two years old (2,13,23,50,59,61,73,74,104,105,111,132). Death resulting from 
pure HBoV1 infection has been reported due to high tilters of HBoV1 (23,85,158). In most 
cases, HBoV1 was detected together with other respiratory pathogens, so the etiological role of 
HBoV1 in respiratory diseases is difficult to confirm. However, careful clinical studies applying 
more accurate markers (quantitative PCR, viral mRNA and antigen detection, and antiviral 
antibody detection), in addition to mere HBoV1 DNA detection by PCR have been done, 
providing accumulating evidence that HBoV1 is an important respiratory pathogen in children 
(2,12,21-23,43,50,52,58,76,80,85,98,103,107,108,111,132,139,158,160,162). Pneumonia, 
bronchiolitis, acute otitis media, common cold, and exacerbation of asthma are the most 
common clinical manifestations of HBoV1 respiratory tract infections, with symptoms of cough, 
fever, rhinitis, wheezing, and diarrhea (2,4,11,14,20,39,48-
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50,58,82,96,98,102,109,111,114,117,124,127,131,132,149,157,158,162). Currently, there are 
no animal models available for HBoV1 in vivo infection. Nevertheless, in in vitro tissue culture, 
HBoV1 infection has been directly demonstrated to cause injuries to cultured human airway 
epithelia, including tight junction disruption, decreased cilia and cellular hypertrophy (42,45,69). 
Genome organization of Bocaparvoviruses 
 Within the genus Bocaparvovirus, the full-length genomes of HBoV1, BPV and MVC 
have been sequenced, including both terminal hairpins (16,119,145). The genome of HBoV1 is 
5,543 nucleotides in length with distinct hairpin sequences and structures at both ends (Fig. 1). 
HBoV1 LEH is 140-nt in length and is predicted to be ‘Y’ shaped with short axial ears, 
mismatches and unpaired bubbles (69). There are no detailed studies on the function of 
bocavirus LEH. In MVM, it has been shown that the MVM LEH is important for transcription 
initiation with the help of non-structural protein 1 (NS1) and plays a critical role in genome 
packaging (89). The bocaparvovirus REH of MVC and BPV, but not HBoV1, harbor sequences 
which have the potential to be folded into cruciform structure near the end tip, although it is less 
favorable thermodynamically for BPV (145). This cruciform structure also appears in MVM, and 
was proved to be required for MVM DNA replication (7,34,36). Bocaparvovirus REH is a perfect 
duplex structure without any mismatch. Notably, MVC LEH and HBoV1, BPV REH were isolated 
both in flip and flop forms, while the other termini of these three viruses were only found in one 
form (69,145).   
The HBoV1 genome encodes two groups of genes encoding non-structural (NS) 
proteins and viral structural (capsid) proteins (VP). NS proteins function in virus replication and 




Figure 1-1. The model of negative sensed HBoV1 genome structure.  
The structure of HBoV1 LEH and REH are modeled with 5’ end and 3’ end sequences 
being labeled. Dotted regions stand for the single stranded DNA region that encodes non-











HBoV1 life cycle 
After the construction of an HBoV1 infectious clone (pIHBoV1), more than 12 different 
cell lines were transfected by pIHBoV1, including HeLa, human embryonic kidney 293 
(HEK293), A549, BEAS-2B cells. Only HEK293 cells were demonstrated to support an efficient 
DNA replication of HBoV1 (69). HEK293 cells were not infected by the virus, suggesting that 
HEK293 cells lack the virus receptor or are inefficient in the intracellular tracking of the virus. 
Notably, a high titer of HBoV1 virions is produced from HEK293 cells transfected with pIHBoV1 
(~5,000 genome copies/cell) (69). The purified virions are infectious to differentiated human 
airway epithelial cells (HAE) cultured on an air-liquid interface (ALI) (45,69), which mimics virus 
infection of the natural host, the human airway epithelia.  
HBoV1 directly infects primary HAE-ALI cultures through either the apical or the 
basolateral surface, suggesting that the virus receptor is expressed on both polarities of the 
airway epithelia (Fig. 1-2, steps 1-2). In general, parvoviruses are believed to enter the cells 
through receptor-mediated endocytosis, as blocking endosome acidification disrupts AAV2 and 
MVM infection (step 3) (8,47,125). Virions traffic to the cytoplasm along microtubules and are 
released from the endosome by an unknown mechanism (130,159). Accumulation of AAV2 
virions were observed in a perinuclear localization, suggesting that nuclear translocation is a 
limiting step (8,165). Virions may also directly disrupt the nuclear envelop to translocate into the 
nucleus (step 4) (27,167). Within the nucleus, the viral genome is released and recognized by 
the cellular replication and repair machinery (step 5, 6). Then, the complementary strand of the 
viral ssDNA genome is synthesized before transcription (step 7), followed by expression of viral 
NS proteins. NS proteins are associated with the viral genome and are required for genome 
packaging (steps 16-18) (15,51,140). However, NS proteins are not packaged into the mature 
virions. The viral DNA replication process likely involves complex hairpin structure changes and 
protein-genome interactions, which produces viral DNA intermediates in different sizes and 
structures. HBoV1 transcription, protein expression and  
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Figure 1-2. The infection life cycle of HBoV1.  
         HBoV1 infection of HAE-ALI is illustrated based on studies of HBoV1 and speculation from 
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DNA replication (steps 8-10, 12-16) are further discussed below. Capsid proteins produced in 
the cytoplasm are assembled into oligomers before translocating into the nucleus (step 11) (95), 
Capsid is assembled in the nucleus, which captures viral ssDNA that is generated in a 
mechanism that is still not clear (steps 17-18) (68,167). Finally, the mature virions are released 
from the nucleus into the cytoplasm and then outside of the infected cells (steps 19-20). 
 
Transcriptional expression profiles of bocaparvoviruses 
 The transcription profiles of BPV, MVC, and HBoV1 were studied during virus infection 
(Fig. 1-3) (17,45,133). The HBoV1 transcription profile was studied in detail by transfection of a 
non-replicated HBoV1 clone, in which both termini were not included (16). All three 
bocaparvoviruses shared similarities in their transcriptional expression profiles but with features 
different from other parvoviruses. Bocaparvoviruses have only one promoter and two 
polyadenylation sites, proximal and distal polyadenylation site [(pA)p and (pA)d] respectively. 
Therefore, bocaparvovirus transcribes one single pre-mRNA from its promoter. This pre-mRNA 
undergoes alternative splicing and alternative polyadenylation. The left half of the viral genome 
encodes NS proteins, and the right half encodes structural proteins (16,119,143,145). One 
unique feature of bocaparvovirus is the expression of NP1 protein, whose ORF is located in the 
middle of the genome (69,119,145). Due to the small genome capacity, NP1 ORF largely 
overlaps with the NS1 ORF at the 3’ end.  
At least 7 mRNA transcripts of HBoV1 were identified, and the splicing of HBoV1 
precursor mRNA (pre-mRNA) appears more complex than those of MVC and BPV (Fig. 1-3). 
Similar to MVC and BPV, HBoV1 utilizes one promoter and two polyadenylation sites located in 
the middle and right end of the genome, respectively. NS1-encoded mRNA is spliced at D2-A2 
sites (intron 2), which results in a shift of the NS1 ORF at the C-terminus. Without splicing of 
intron 2, the unspliced N1-encoding mRNA expresses NS1-70 protein which is terminated early  
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Figure 1-3. Transcription maps of HBoV1, BPV and MVC.  
The approximately 5.6 kb genomes of the three bocaparvoviruses shown is based on 
previous publications (16,119,145). The major transcription landmarks include the terminal 
repeats (LEH and REH), promoter (P), splice donors (D) and acceptors (A), and (pA)p and 
(pA)d sites. All identified mRNA transcripts are listed below the map (designated R1 to R6), 
with their respective sizes shown on the left and the expected MW of the expressed proteins 










at the NS1 ORF. An additional A1-1 splice site was identified, but its implications for viral NS 
protein expression was unknown (16). Intriguingly, three major NS proteins were detected by 
using an anti-NS1 C-terminus antibody in either HBoV1 DNA-transfected or HBoV1 infected 
cells (31). The largest NS protein was believed to be the full-length NS1 at a MW of ~100 kDa, 
however, the nature of the other two small NS bands is unknown (16). R3 and R4 mRNAs that 
are spliced at both D1-A1 and D2-A2 introns, are responsible for NP1 expression.  
 R5, R6 and R7 mRNAs are proposed to encode HBoV1 VP proteins, all of which are 
spliced at the D1 donor site and the A1, A2, and A3 acceptors, respectively (Fig. 1-3). Northern 
blot analysis of the RNA isolated from infectious clone-transfected cells showed that the R5 
mRNA was the most abundantly expressed VP-encoding mRNA. However, there is a translation 
initiation codon downstream of the A1 site and upstream of VP-encoding region, which does not 
seem to be used during VP translation. This leaking mechanism is commonly used in members 
of the Densovirinae subfamily but is unusual for vertebrate parvoviruses (55,93,153). Moreover, 
the VP2 protein is translated from a non-canonical start codon (GUG) located between VP1 and 
VP3 (173). The (pA)d signal localizes immediately upstream of VP stop codon. There is a large 
genome sequence between the VP-encoding region and the REH with an unknown function. 
Functions of the NS proteins of bocaparvovirus  
The amino acid conservation between BPV and MVC NS1 protein versus HBoV1 NS1 is 
31% and 39%, respectively. NS1 is the key protein for parvovirus DNA replication (29,32). In 
bocaparvovirus, NP1 is also indispensable for viral DNA replication. Interestingly, BPV and MVC 
NP1 are exchangeable with each other, and HBoV1 NP1 could also supplement the function of 
MVC NP1 (145). Though there is a relatively low similarity among the NP1 of different 
bocaparvoviruses in amino acid sequence, NP1 seems functionally conserved.    
Parvovirus NS1, also named replication protein 78/68 (Rep78/68) for AAVs, could be 
functionally divided into three domains. The N-terminal domain binds the replication origin (Ori) 
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of viral RF DNA, referred to as the origin-binding domain (OBD), which has both sequence and 
strand specific endonuclease activity (152). The OBD structures of AAV5 Rep68, MVM NS1 and 
HBoV1 NS1 have been resolved (54,150,152). Superimposition of the OBDs of these three 
proteins displayed a conserved beta-sheet core, flanked by several alpha helices on both the 
left and right sides (152). They share similarities with and belong to the HUH-nuclease 
superfamily. One loop and an alpha helix protrusion are sequence specific and specifically bind 
to Ori DNA major and minor grooves. For AAVs, the interaction between Rep78/68 OBD and 
the Ori has been studied in detail by analyzing the structure of the Rep78/68 and Ori complex 
(72). Rep78/68 oligomerizes and binds to sequence specific tetra-nucleotides repeats (67,72). 
In HBoV1, the two DNA binding regions of the HBoV1 OBD are highly positively charged, but 
their specific interactions with DNA have not been confirmed.  
The middle domain of Rep78/68 and NS1 protein contains four conserved walkers motif 
(boxes A, B, B’ and C), which belong to the SF3 helicase family and perform 3’-5’ helicase 
function (35,62,72). The C-terminal domain of bocaparvoviruses are longer than other 
parvoviruses, and the HBoV1 C-terminal domain is one of the longest. It is predicted to have 
transactivation capability but its function is largely unknown (88,137). The molecular weight for 
BPV and MVC NS1 are 95 kDa and 80 kDa, respectively. The C-terminal domains of the three 
bocaparvoviruses share two conserved domains, of which the function is unknown (16). 
Intriguingly, HBoV1 NS1 appeared to have an increase of ~12 kDa in size on SDS-PAGE gel. 
There is evidence to support that this size increase is due to the C-terminal domain (134). We 
wonder whether this size increase could be a covalently linked post-translational modification at 
the C-terminus domain.  
The function of bocaparvovirus NS2 has not been studied. However, its coding 
sequence largely overlaps with NS1, and thus they possibly share similar functions as the Rep 
78 vs Rep 52 of AAVs. Rep52 shares the helicase domain, and C-terminal domain with Rep78. 
Rep52 plays an important role in viral genome packaging (83,136).  
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Conserved among all bocaparvoviruses, NP1 has ~200 aa and is expressed from an 
ORF that overlaps with the C-terminus of the NS1. NP1 plays a significant role in viral DNA 
replication. It has a non-canonical nuclear localization signal located at 7-50 aa (92). 
Transfection with a NP1-knockout mutant of either HBoV1 or MVC barely produced monomeric 
and dimeric RF DNA of viral replication intermediates (69,143). The function of the three NP1 
proteins in viral DNA replication is conserved since they are exchangeable for MVC DNA 
replication (145). Notably, NP1 could also overcome the deficiency of NS2 of MVM at the early 
replication stage by localizing at the viral DNA replication centers, but could not compensate for 
the late steps of MVM infection after virions are produced (106). Moreover, NP1 plays multiple 
roles during processing viral pre-mRNA (53,143,173). Both MVC and HBoV1 NP1 help 
transcription read through the (pA)p site to generate full-length VP-encoding transcripts. 
Moreover, HBoV1 NP1 facilitates viral mRNA splicing at the D3-A3 sites, which helps VP mRNA 
production and protein expression (173).  
Structural proteins of bocaparvoviruses  
Bocavirus VP proteins are structural proteins for capsid assembly. Different from BPV 
and MVC, HBoV1 expresses three VP proteins, and the VP2 uses a non-canonical start codon 
(173). More interestingly, construction of VP1 cDNA under human cytomegalovirus (CMV) 
immediate early gene promoter could not initiate VP1 translation. The capsid proteins are 
expressed in a ratio ~1:1:10 during infection, which is similar to that of AAVs. VP3, the main 
structure protein, can form virus like particles (VLPs), which contain putative neutralization and 
receptor binding sites (64). A monoclonal antibody 15C6 has been developed that reacts with all 
the VLPs formed by HBoV1, 2 or HBoV3 (64). In addition, most Parvovirinae members, except 
Aleutian mink disease virus (AMDV), contain a phospholipase A2 (PLA2) domain within the VP1 
unique region (VP1u). Because of the newly identified VP2, HBoV1 has a short VP1u of 90 aa. 
Conserved with other parvoviruses, the VP1u region exhibits a PLA2 activity within the domain 
11-66 aa (78,171).  The PLA2 domain and function of the VP1u was also confirmed in MVC 
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(145). This activity is proposed to be important for sequential structural changes from receptor 
mediated endocytosis to endosome escape.  
In the absence of VP1 (and VP2 for HBoV1), VLPs can be formed by expression of only 
VP2 (VP3 for HBoV1) from insect cells infected with VP2-expressed baculovirus. VLP structures 
of parvoviruses have been resolved by cryo-electrophoresis microscopy, 3-D reconstruction and 
X-ray crystallization (38,60,64,75,81,161). Conserved with other parvovirus structures, HBoV1 
shares the icosahedral 5-fold axis tunnel, 3-fold axis trimeric protrusions and a 2-fold axis 
depression. BPV is different in a raised surface loop at the two-fold axis. Both of them have a 
conserved core with one alpha-helix linked with 8 beta sheet structure but different in emanating 
loop(s) radially under the 5-fold axis tunnel (64,75). These differences produce new surface 
structures for both viruses and may be important for vaccine development.  
 
 DNA replication of autonomous parvovirus  
 
The proposed model of parvovirus DNA replication is different between 
dependoparvovirus and autonomous parvoviruses (6,7,10,30,35,128,164). Autonomous 
parvovirus DNA replication could be summarized as a hairpin transfer model (Figure 1-4), 
which is derived from MVM studies (35,116,146,147). MVM has a ‘Y’ shaped LEH with two 
mismatches within the stem sequence (Figure 1-4). The REH is linear in structure, with one 
mismatch in the stem and another mismatch at the tip. Upon entering the nucleus, the viral 
genome is recognized by cellular DNA replication polymerase that synthesizes the 
complementary strand, primed by the 3’-OH at the LEH (Figure 1-4, Step 1). Upon reaching the 
5’ end of the genome, the DNA polymerase is stopped by the duplex structure, and a “nick” is 
left in the genome. After the ligation of the “gap” by a cellular DNA ligase, a covalently closed 
double-stranded DNA (cc RF DNA) with mismatches on both ends is formed. Acting as a 
transcription template, this molecule produces viral NS proteins, which are translocated into the 
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Figure 1-4. The replication model of MVM.  
A negative sense MVM genome is diagrammed with the ‘Y’ shaped LEH and “U” shaped 
REH at the ends. The complementary strand of the viral ssDNA is synthesized by cellular DNA 
polymerase through priming of the 3’-OH at LEH (Step 1). The newly synthesized strand is 
ligated with the 5’ end of the REH, followed with specific nicking performed with NS1 (Step 2).  
NS1 is then covalently linked at the newly nicked 5’ end (Step 3). Oligomerized NS1 and the 
cellular replication machinery open and copy the REH (Steps 3-4). The 3’ REH is refolded into a 
hairpin structure and uses itself as a template to replace the lower strand DNA (Steps 5-6). 
Further extension of 3’ end leads to the formation of dRF DNA (Step 7). The extended 3’ REH 
refolds again and progresses further for DNA synthesis, resulting in tetrameric RF DNA (Steps 








nucleus and specifically recognizes the NS1-binding site on the REH. NS1 has endonuclease 
activity, and nicks the REH at a NS1-specific nicking site upstream of the NS1-binidng site. 
Meanwhile, the helicase activity of NS1 facilitates unfolding (extending) the REH. Then, cellular 
DNA polymerase copies the extended REH into the upper strand (primed by the 3’-OH released 
from the NS1 specific nicking). This step is called hairpin transfer (Figure 1-4, Steps 3-4). This 
intermediate is named monomer replication form (mRF) DNA. Interestingly, NS1 protein 
covalently links to the 5’ end of the replication intermediate. With the help of NS1, both strands 
of the extended REH are refolded into hairpin structures, while the one with 3’─OH is further 
synthesized by using itself as a template (Figure 1-4, steps 5-6). The lower strand is thus 
replaced by the newly synthesized DNA. This step is called strand-displacement.  
The product of the strand-displacement is dimeric RF DNA intermediate (dRF) (Figure 
1-4, Step 7). As the tetrameric size of RF DNA was frequently detected during MVM DNA 
replication (on Southern blotting of 2-dimentional gel to resolve DNA structures) (155), it is 
believed that the dRF DNA goes through the hairpin refolding and strand-displacement steps 
again (Figure 1-4, steps 8-9). The tetrameric RF DNA is resolved on both the LEH and the 
REH, which produces ssDNA genomes that are packaged by empty virions.  
For HBoV1 replication, NS1 and NP1 are both required. They localize within the nucleus 
but their interaction has not been examined (16). During MVM replication, it has been reported 
that cellular factors binds LEH or REH. These DNA binding sites have been shown to be 
necessary for the MVM DNA replication (25,26,34). For the HBoV1 replication of HBoV, such 
cellular factors have not been identified yet.  
In members of the Parvovirinae subfamily, the NS1/Rep78/68 binding sequences harbor 
tetra-nucleotides repeats (29,97,142,151,166). MVM has cognate or degenerated NS1 binding 
sites throughout its genome (24). However, Densoviruses Galleria mellonella densovirus 
(GmDNV) and Junonia coenia densovirus (JcDNV) contain an NS1 binding site of trimer 
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nucleotides repeated four times (46,153). The binding and nicking properties of bocaparvovirus 
NS1 with their respective genomes have not yet been explored.  
It is well acknowledged that the full-length hairpin sequences of parvoviruses are 
required for their replication in the so called rolling hairpin DNA replication model as described 
above. However, B19 could replicate with truncated termini, which could not form hairpin 
structures (63). This phenomenon is repeated during HBoV1 DNA replication in the HBoV1-
transfected HEK293 cell system (16). The mechanism underlying hairpin structure-independent 







Chapter II:  






Human bocavirus 1 (HBoV1) is a single-stranded DNA parvovirus that causes lower 
respiratory tract infections in young children worldwide. In this study, we identified novel splice 
acceptor and donor sites, namely A1’ and D1’, in the large non-structural protein (NS1)-
encoding region of the HBoV1 precursor mRNA. The novel small NS proteins (NS2, NS3, and 
NS4) were confirmed to be expressed following transfection of an HBoV1 infectious proviral 
plasmid and viral infection of polarized human airway epithelium cultured at an air-liquid 
interface (HAE-ALI). We constructed mutant pIHBoV1 infectious plasmids which harbor silent 
mutations smA1’ and smD1’ at the A1’ and D1’ splice sites, respectively. The mutant infectious 
plasmids maintained production of HBoV1 progeny virions at a level less than five times lower 
than that of the wild-type plasmid. Importantly, the smA1’ mutant virus that does not express 
NS3 and NS4 replicated in HAE-ALI as effectively as the wild-type virus, however, the smD1’ 
mutant virus that does not express NS2 and NS4 underwent an abortive infection in HAE-ALI. 
Thus, our study identified three novel NS proteins, NS2, NS3, and NS4, and suggests an 




Human bocavirus 1 (HBoV1) belongs to genus Bocaparvovirus of the Parvoviridae 
family (3). HBoV1 causes lower respiratory tract infections, especially in infants less than two 
years old (2,23,104,105,111). Severe and deadly cases associated with high viral load, anti-
HBoV1 IgM antibody detection, or increased IgG antibody production, have been documented 
21 
 
(23,85,158). In vitro, HBoV1 infects polarized primary human airway epithelium cultured at an 
air-liquid interface (HAE-ALI) (45), and causes damage of the airway epithelium (40,42,69). 
Currently, no specific treatments for HBoV1 infection are available for hospitalized infants.    
The RNA transcription profiles of three species in the genus Bocaparvovirus, i.e., canine 
minute virus (CnMV/MVC) (133), bovine parvovirus type 1 (BPV1) (17), and HBoV1 (45), have 
been studied during virus infection. These species share similarities in their gene expression 
with distinguishing features among various parvovirus clades. They use one promoter to 
transcribe a single precursor mRNA transcript (pre-mRNA), which is both alternatively spliced 
and polyadenylated, to generate matured mRNA transcripts for encoding viral non-structural 
(NS) and structural (VP) proteins (16,119,144,145). Members of Bocaparvovirus express one 
large NS protein (NS1) from the left viral genome, VP proteins from the right side of the viral 
genome, and at least one small NS protein (NP1) that is encoded by an open reading frame 
(ORF) located in the middle of the viral genome (69,119,145). During MVC infection, we have 
detected another small NS protein (NS1~66kd), which contains the N-terminus of the NS1 
(144). 
The Bocaparvovirus NS1, like the NS1 or Rep78/68 of other parvoviruses, is a 
multifunctional protein that has site-specific origin DNA binding domain (OBD) endonuclease 
activity at its N-terminus (152),  ATPase and helicase activities in the middle (35,62), and a 
transactivation domain at its C-terminus (88,137). NS1 is essential to viral DNA replication, 
while NP1 is required for efficient viral DNA replication (69,145). MVC NP1 protein plays a role 
in facilitating VP-encoding mRNAs to read through the proximal polyadenylation site that lies in 
the middle of the viral genome (144). Nothing is known about the functions of the newly 
identified MVC NS1~66kd protein. The protein expression profile of HBoV1 has been 
characterized using an incomplete HBoV1 genome lacking both the left and right inverted 
termini by transfection (16). Expression of the NS1, NP1 and VP from their respective encoding 
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transcripts were identified, however, the identities of the NS proteins with approximately (~) 
molecular weight (MW) of 66 kDa and 34 kDa, which were detected by an anti-NS1 C-terminus 
antibody, are unknown (16).   
In this study, we explored the expression profile of HBoV1 NS proteins in transfection of either 
non-replicating plasmids or replicating infectious plasmids in HEK293 cells, or during HBoV1 
infection of HAE-ALI cultures. We identified three novel HBoV1 NS proteins, NS2, NS3, and 
NS4, in both the HBoV1 genome replicating 293 cell system and the HBoV1 infection of HAE-
ALI system. The functions of these proteins were further explored in these two systems.   
 
Materials and Methods 
 
Cell culture  
Cell line: Human embryonic kidney 293 (HEK293) cells (CRL-1573) were obtained from 
American Type Culture Collection (ATCC, Manassas, VA), and were cultured in HyClone™ 
Dulbecco’s Modified Eagle Medium (DMEM, GE Healthcare Bio-Sciences, Piscataway, NJ) with 
10% fetal calf serum (FCS, #F0926, Sigma-Aldrich, St Louis, MO). 
Primary human airway epithelium cultures: Polarized human airway epithelium 
cultures at an air-liquid interface (ALI), termed HAE-ALI, were generated by growing isolated 
human bronchial airway epithelial cells on collagen-coated, semipermeable membrane inserts 
(0.33 cm2, Transwell®, Corning, Corning, NY). They then were allowed to differentiate at an air-
liquid interface (ALI) either in an Ultraser G-containing medium as described previously (69) or 
in PneumaCult™-ALI medium (StemCell, Vancouver, BC, Canada), in 5% CO2 at 37°C. After 3-
5 weeks, the polarity of the HAE-ALI cultures was determined based on the transepithelial 
electrical resistance (TEER), the cultures that had a TEER of over 1,000 Ω.cm2 were used for 




DNA constructs  
pHBoV1NSCap-based constructs: The parent pHBoV1NSCap that harbors HBoV1 NS 
and Cap genes but lacks the left and right termini (GenBank accession no.: DQ000496) (16) 
was used to construct pHBoV1NS1HACap, in which an HA tag sequence was inserted after the 
ATG of the NS1 coding sequence. pHBoV1NS1HA65*Cap and pHBoV1NS1HA303*Cap were 
constructed by inserting a stop codon in the NS1 coding sequence after amino acid residue (aa) 
65 and 303, respectively, in the pHBoV1NS1HACap. pHBoV1NS1HA296StrepCap was constructed by 
further introducing a Strep tag after aa 296 of the NS1 coding sequence. 
pHBoV1NS1HA65*Cap(smA1’) and pHBoV1NS1HA303*Cap(smD1’) were constructed by moving the 
smA1 and smD1’ mutations, as described below, into pHBoV1NS1HA65*Cap and 
pHBoV1NS1HA303*Cap, respectively.  
pIHBoV1-based constructs: pIHBoV1, the infectious plasmid clone of HBoV1, which 
contains the HBoV1 full-length genome (GenBank accession no.:JQ923422), has been 
described previously (69). pIHBoV1(smA1’) and pIHBoV1(smD1’) were constructed by mutating 
the A1’ acceptor site “AG/C” at nt 1015 to “TC/G” and the D1’ donor site “G/GTAGGA” at nt 
1212 to “A/GTTGGC”, respectively, in pIHBoV1.   
pGEX-4T-3-based constructs: The NS1-encoding sequences, nt 349-708 and nt 349-
1284 were inserted into pGEX-4T-3 vector (GE Healthcare) to generate pGEX-4T-NS1N and 
pGEX-4T-NS1NL, respectively.  
pGEM-4Z-based construct: Plasmid p4Z-PA1’D1’ was constructed by inserting HBoV1 




All nucleotide (nt) numbers of the HBoV1 genome refer to the HBoV1 full-length genome 
(GenBank accession no.:JQ923422), unless specified. Constructs were verified for HBoV1 
sequence by Sanger sequencing at MCLAB (South San Francisco, CA)    
 
Antibody production and antibodies used 
 
 pGEX-4T-3-based plasmids were used to express GST-fused HBoV1 NS proteins, 
GST-NS1aa1-120 and GST-NS1aa1-313. These proteins were used for the production of anti-
NS1 N-terminus short (anti-NS1N) and anti-NS1 N-terminus long (anti-NS1NL), respectively. 
Purified GST-fused proteins were used to immunize rats following the antiserum production 
protocol that was described in our previous publication (145). All animal procedures were 
approved by the Institutional Animal Care and Use Committee of the University of Kansas 
Medical Center. Anti-NS1 C-terminus aa 640-781 antibody (anti-NS1C), anti-HBoV1 NP1 
antibody (anti-NP1), and anti-HBoV1 VP antibody (anti-VP) have been described previously 
(16,69). Anti-HA (clone HA-7, Sigma), anti-Flag (clone M2, Sigma), anti-Strep (Clone 5A9F9, 
Genscript, Piscataway), anti-β-actin (#A5441, Sigma), anti-β-tubulin IV (#T7941Sigma), and 
anti-ZO-1 (#610966, BD Biosciences) were purchased.  
 
Transfection 
HEK293 cells grown in 60-mm dishes were transfected with 3 µg of plasmid as indicated 
in the figures, LipoD293 transfection reagent (SignaGen, Rockville, MD) was used following 




RNA isolation and RNA analyses  
RNA isolation. At 48 hours (hrs) post-transfection, transfected HEK293 cells from two 
60-mm dishes were used to extract total RNA using TRIzol® reagent (Life Technologies). At 14 
days post-infection (p.i.), at least 2 infected HAE-ALI cultures were used for total RNA extraction 
using TRIzol® reagent following manufacturer’s instructions.    
RT-PCR. For identification of A1’ and D1’ splice sites, viral cDNA was synthesized by 
using M-MLV kit (Life Technologies) and HBoV1-specific primer (HBoV1 nt 2560-2536). PCR 
reactions were performed using forward (F) and reverse (R) primers as indicated in Fig. 1A. 
PCR fragments were sequenced at MCLAB. Oligos were synthesized at IDT (Coralville, IA). 
RNase protection assay (RPA). Probe PA1’D1’ was generated by in vitro transcription 
of the EcoRI-linearized p4Z-PA1’D1’ plasmid using T7 RNA polymerase. Ten µg of the total 
RNA was used for RPAs, following the methods described previously (122). Gels were imaged 
using a GE Typhoon FLA 9000 and processed with ImageQuant TL 8.1 (GE Healthcare) 
software for quantification. 
  
DNA isolation and Southern blotting  
Low-molecular-weight (Hirt) DNA was extracted and digested with or without DpnI 
essentially as previously described (63). DNA samples were run on a 1% agarose gel, and 
Southern blotting was performed as described previously (118). The blot was hybridized with an 
HBoV1 NSCap probe (16), and was then processed using a GE Typhoon FLA 9000 and 




Immunoprecipitation, SDS-polyacrylamide gel electrophoresis (PAGE) and Western 
blotting 
Pierce™ Crosslink IP Kit (#26147, Life Technologies) was used for immunoprecipitation. 
At 48 hrs post-transfection, HEK293 cells from a 60-mm dish were collected and lysed for 
immunoprecipitation with an anti-HA or anti-Strep antibody following the manufacturer’s 
instructions.  
 Immunoprecipitated proteins, or cell lysates taken 2 days post-transfection or 14 days 
p.i., were separated by SDS-10%PAGE, except the blots shown in panels of Fig. 4C&E, and 
Fig. 7C&D, which were separated by SDS-8%PAGE. Proteins were then electrotransferred onto 
a nitrocellulose membrane. The membrane was first blocked in 5% nonfat milk in 20mM Tris-
HCl, pH7.6, 150 mM NaCl buffer with 0.1% Tween 20 (TBST), then incubated with a 
monoclonal antibody against Flag, HA, or Strep tag, or with anti-sera raised against various 
regions of the HBoV1 NS1 (anti-NS1N, anti-NS1NL, or anti-NS1C), or with anti-NP1, anti-VP, 
and anti-β-actin. Thoroughly washed with TBST after each step of incubation, the membrane 
was incubated with an HRP-conjugated secondary antibody (Jackson ImmunoResearch Inc., 
West Grove, PA), and subsequently with SuperSignal West Pico Chemiluminescent Substrate 
(Life Technologies) for signal development under the imager FUJIFILM LAS 4000 (FUJIFILM 
Life Sciences). Images were processed with Multi Gauge V2.3 software (FUJIFILM Life 
Sciences).     
 
Virus production and infection  
Virus production: HEK293 cells cultured on five 145-mm plates in DMEM-10%FCS 
were transfected with 30 µg of pIHBoV1 or its mutant per dish using PEI (1 mg/ml, #23966, 
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Polysciences, Warrington, PA) at a ratio of  DNA:PEI=1:2. At two days post-transfection, cells 
were lysed for virus purification as previously described (69).   
Virus infection of HAE-ALI: Polarized HAE-ALI cultures were apically infected with 
purified virus at a multiplicity of infection (MOI) of 10 DNaseI-resistant particles (DRP) per cell in 
50 µl of phosphate buffered saline, pH7.4 (PBS). After incubation for 2 hrs, apical medium was 
aspirated, and the insert was washed 3 times with PBS. Following infection, released virus was 
collected daily by incubating the apical side of the insert with 100 µl of PBS.     
Both purified virus preparations and the viruses released from the apical side were 




At 14 days p.i., HAE-ALI membranes were fixed with 3.7% paraformaldehyde in PBS at 
room temperature for 15 min. The fixed membranes were cut into small pieces. We then 
performed immunofluorescence assay with anti-NS1C and anti-β-tubulin IV or with anti-NS1C 




Novel splice sites, A1’ acceptor and D1’ donor, are used in processing of HBoV1 pre-
mRNA. 
We have identified a novel splice donor site, 1D’, that lies in the first intron of the pre-
mRNA of Bocaparvovirus MVC (144). We suspected the presence of a similar donor site in 
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HBoV1 pre-mRNA (Fig. 2-1A, D1’). In addition, we previously identified an A1-1 acceptor site in 
the first intron of HBoV1 pre-mRNA (Fig. 2-1A, A1’) (16). To confirm the alternative use of these 
two splice sites in the processing HBoV1 pre-mRNA, we designed two primer pairs to detect 
viral mRNA transcripts spliced at D1’, A1’ or both sites in total RNA isolated from 
pHBoV1NSCap-transfected 293 cells. The primer pair of F287 and R1210 amplified a DNA 
fragment of ~250 bp (Fig. 2-1B, RT-PCR 1). Sequencing confirmed that the A1’ acceptor site is 
used at nt 1017 (Fig. 2-1C, RT-PCR 1). Another primer pair, F1021 and R2250, amplified a 
band of ~300 bp (Fig. 2-1B, RT-PCR 2). Sequencing showed that the D1’ site is used at nt 
1212 (Fig. 2-1C, RT-PCR 2).   
Next, using RPAs, we employed an anti-sense RNA probe spanning nt 916-1263 to 
determine the relative abundance of the HBoV1 mRNAs which were alternatively spliced at the 
A1’ and D1’ splice sites (Fig. 1A, PA1’D1’). In the RNA samples isolated from transfected cells, 
we detected 4 protected bands indicated in Fig. 2-1D, as predicted (Fig. 2-1A), confirming the 
involvement of the A1’ and D1’ splice sites in processing HBoV1 pre-mRNA. By quantifying 
these bands, we found that ~5% of the protected viral RNAs were spliced at either the A1’ or 
D1’ splice site in pre-mRNAs generated from either the non-replicating pHBoV1NSCap or the 
replicating pIHBoV1 plasmid (Fig. 2-1D, D1’ and A1’ Spl). However, the replicating pIHBoV1 
generated less RNAs spliced at both splice sites than did the non-replicating pHBoV1NSCap in 
transfected cells (Fig. 2-1D, All Spl). The involvement of the A1’ and D1’ splice sites was further 
validated in the processing of viral pre-mRNA during HBoV1 infection of HAE-ALI (Fig. 2-1E, 
lane 3). Notably, virus infection produced much less viral RNA spliced at both the A1’ and D1’ 
sites than did the pIHBoV1 in transfection (Fig. 2-1E, lane 3 vs. Fig. 1D, lane 4, All Spl).  
Since the HBoV1 pre-mRNA is significantly spliced at the A1’ and D1’ splice sites, we 
searched for potentially encoded small NS proteins spanning the NS1 coding sequence from 
these alternatively spliced mRNAs. As shown in Fig. 2-2, R2S/L mRNA, in which the D1’-A1  
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Figure 2-1. HBoV1 pre-mRNA is processed at novel A1’ acceptor and D1’ donor sites. 
(A) Primers and probe used to detect viral mRNAs spliced at the A1’ and D1’ 
splice sites. The genome of HBoV1 is shown to scale with transcription landmarks, including 
the P5 promoter, splice donor (D1, D1’, D2 and D3) and acceptor (A1, A1’, A2 and A3) sites, the 
internal proximal polyadenylation site [(pA)p], and the distal polyadenylation site [(pA)d]. The 
RPA probe PA1’D1’ (nt 916 to 1263) is shown, along with the designated bands that are 
expected to protect and their predicted sizes (nts). Primers used for RT-PCR are also shown. 
(B&C) RT-PCR analyses of HBoV1 RNAs. Total RNA was isolated from HEK293 cells 
transfected with pHBoV1NSCap. cDNA was synthesized and amplified with two pairs of HBoV1-
specific primers as shown. (B) Amplified DNA fragments were electrophoresed on 1.6% 
agarose gel and visualized using ethidium bromide staining. (C) The amplified DNA fragments 
were excised from the agarose gel and purified. The purified DNA was subjected to sequencing 
by Sanger method. The histograms of the sequences at the exon junctions of D1/A1’ and 
D1’/A1 splice sites, with alignment of the sequences with the HBoV1 genome sequence (at the 
bottom), are shown. (D&E) Determination of the usage of the D1’ and A1’ splice sites by 
RPA. Ten μg of total RNA isolated at 2 days post-transfection from pBluescript SK (Ctrl), 
pHBoV1NSCap- and pIHBoV1-transfected 293 cells (D) or at 14 days p.i. from mock- and 
HBoV1-infected HAE cells (E), was protected by the P1A1’D1’ probe as indicated. Lane 1 (M), 
32P-labeled RNA markers (121), with sizes indicated to the left. The origins of the protected 







Figure 2-2. Putative expression of HBoV1 NS proteins from alternatively processed 
mRNAs.     
A putative expression profile of HBoV1 NS proteins is shown with transcription 
landmarks and putative NS proteins. Major species of HBoV1 mRNA transcripts that are 
alternatively processed at the A1’ and D1’ splice sites and their putatively encoding NS proteins 
are shown with their relative sizes (minus a poly A tail of ~150 nts). Putative protein sizes and 
the actually detected sizes in the next experiments are shown side by side at the right. 








intron is excised, can express NS2 protein, R3 S/L mRNA, in which the D1-A1’ intron is excised, 
can translate NS3 protein, and R4 S/L mRNA, in which both the D1-A1’ and D1’-A1 introns are 
excised, is expected to have the capability to translate the NS4 protein.   
The predicted sizes of the NS2, NS3, and NS4 proteins are 53.8, 56.7, and 22.2 kDa, 
respectively. However, in both HBoV1 plasmid-transfected and virus-infected cells, we 
previously detected two NS protein bands at ~66 kDa and ~34 kDa, in addition to the NS1 band 
at ~100 kDa, using an anti-NS1C antibody (Fig. 2-2, α-NS1C) (16,69). NS1’s predicted MW of 
88.2 kDa led us to speculate that the C-terminus of the NS1 is highly post-translationally 
modified, which gives an increment of ~12 kDa in its apparent molecular weight. Since all the 
predicted NS2, NS3, and NS4 proteins share the C-terminus with the NS1, we further postulate 
that NS2, NS3, and NS4 experience similar post-translational modification, resulting in detected 
MW of ~66, ~69 and ~34 kDa, respectively, with an increment of ~12 kDa from the modification 
(Fig. 2-2).   
In addition, an in-frame stop codon would terminate NS protein expression in viral 
mRNAs that retain the D2-A2 intron. NS1-70, NS2’, NS3’, and NS4’ could be expressed from 
the R1m, R2m, R3m and R4m mRNAs (Fig. 2-2), which are not abundantly expressed mRNAs, 
since splicing of the D2-A2 intron is efficient. The ratio of spliced vs. unspliced RNA at the D2 
site is over 20:1 (16). NS1-70 has been detected previously in HBoV1 plasmid-transfected cells 
(16).  
Detection of NS2, NS3, and NS4 proteins in HEK293 cells transfected with non-replicating 
HBoV1 constructs.   
In the following sets of experiments, we aimed to validate expression of NS2, NS3 and 
NS4 in HEK293 cells transfected with pHBoV1NSCap-based plasmids. We first introduced a 
stop codon to experimentally early terminate the NS1 and NS3 coding sequences in 
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pHBoV1NS1HACap. Transfection of the pHBoV1NS1HA303*Cap produced two major protein bands 
at ~66 kDa and ~35 kDa, as detected by an anti-HA antibody (Fig. 2-3B, lane 3), supporting the 
notion that the NS1 was truncated to ~35 kDa. The truncated NS3 should be ~3 kDa and was 
undetectable on the blot. We believe that the ~66 kDa band is NS2, which is assumed to be 
translated from the NS2 mRNAs that excise the D1’-A1 intron (Fig. 2-3A, NS2). A weak band at 
~37 kDa was also detected by the anti-HA, which fits the size of NS2’ (Fig. 2-3A, NS2’). Since 
NS1-70 was detected at a much lower level relative to the abundant NS1 (Fig. 2-3B, lane 2), we 
believe that the NS1-70, NS2’, NS3’, and NS4’ proteins are minimally expressed.         
We next introduced a stop codon after aa 65 of the NS1 coding sequence in 
pHBoV1NS1HACap, which early terminates both the NS1 and NS2 proteins, but not the NS3 and 
NS4 proteins. Using an anti-NS1C antibody, we detected only protein bands at ~66 kDa and 
~34 kDa in pHBoV1NS1HA65*Cap-transfected cells (Fig. 2-3D, lane 3), which confirms that the 
NS1 and NS2 proteins are early terminated, and suggests that NS3 and NS4 proteins are 
expressed. On the other hand, only bands at ~66 kDa and ~34 kDa were detected in 
pHBoV1NS1HA303*Cap-transfected cells (Fig. 2-3D, lane 4), confirming that NS2 and NS4 
proteins are expressed. When all the NS1, NS2 and NS3 coding sequences were early 
terminated in pHBoV1NS1HA65*303*Cap (Fig. 2-3C), only NS4 protein was detected in transfected 
cells (Fig. 2-3D, lane 5), validating the expression of NS4 from the mRNAs that excised both the 
D1-A1’ and D1’-A1 introns.     
Furthermore, we tagged the NS1 coding sequence with an HA tag after aa 1 and with a 
Strep tag after aa 296 that lies in the intron of D1’-A1 in pHBoV1NSCap (Fig. 2-4A), and used 
an immunoprecipitation (IP) strategy to confirm the expression of NS2, NS3 and NS4. Anti-HA 
antibody-conjugated beads were used to pull down HA-tagged NS proteins from the lysate of 
the HEK293 cells transfected with pHBoV1NS1HA296StrepCap. In the precipitated proteins, we  
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Figure 2-3. Detection of HBoV1 NS1, NS2, NS3, and NS4 proteins in HEK293 cells 
transfected with pHBoV1NSCap-based plasmids. 
(A&B) Expression of HBoV1 NS2 protein. (A) Expected HA-tagged NS proteins 
expressed from pHBoV1NS1HA303*Cap. The NS-encoding viral mRNAs, which have the potential 
to produce HA-tagged NS proteins and C-terminus-containing NS proteins, are diagramed. The 
expected NS proteins and their predicted and detected sizes are shown at the right.  (B) 
HEK293 cells were transfected with pHBoV1NS1HACap or pHBoV1NS1HA303*Cap as indicated. At 
two days post-transfection, cells were lysed for Western blotting using an anti-HA antibody.   
(C&D) Expression of HBoV1 NS3 and NS4 proteins. (C) Expected NS1 C-terminus (NS1C)-
containing NS proteins expressed from pHBoV1NS1HA65*Cap and pHBoV1NS1HA65*303*Cap. The 
NS-encoding viral mRNAs, which have the potential to produce NS1C-containing NS proteins, 
are diagramed. The expected NS proteins and their predicted and detected sizes are shown at 
the right.  (D) HEK293 cells were transfected with pHBoV1NSCap-based plasmids as indicated. 









Figure 2-4. Detection of HBoV1 NS1, NS2, NS3, and NS4 proteins in transfected HEK293 
cells using immunoprecipitation assays.     
(A) Putative NS expression from transfection of the pHBoV1NS1HA296StrepCap 
plasmid. A putative expression profile of HBoV1 NS proteins is schematically diagramed with 
only HA, Strep, or NS1 C-terminus-containing NS-encoding mRNAs. Sizes of the putative NS 
proteins and the actually detected sizes are shown side by side at the right. (B-D)  Western 
blot (WB) analysis of the NS proteins immunoprecipitated (IP) by an anti-HA antibody. 
HEK293 cells were transfected with pHBoV1NS1HA296StrepCap. At two days post-transfection, 
cells were lysed for immunoprecipitation using the anti-HA antibody or mouse IgG (as a control). 
Precipitated proteins, together with 10% of the input cell lysate, were analyzed by Western blot 
using anti-HA (B), anti-Strep (C), and anti-NS1C (D) antibodies, respectively. (E-G)  Western 
blot analysis of the NS proteins immunoprecipitated by an anti-Strep antibody. HEK293 
cells were transfected with pHBoV1NS1HA296StrepCap. At two days post-transfection, cells were 
lysed for immunoprecipitation using the anti-Strep antibody or mouse IgG (as a control). 
Precipitated proteins, together with 10% of the input cell lysate, were analyzed by Western blot 
using anti-HA (E), anti-Strep (F), and anti-NS1C (G) antibodies, respectively. The identities of 
detected protein bands are shown with lines to the left of the blot. The asterisk indicates bands 







detected NS1 at ~100 kDa using anti-HA, anti-Strep, or anti-NS1C antibodies (Fig. 2-4B-D, lane 
3). However, an NS protein at ~66 kDa was only detected with an anti-HA or anti-NS1C   
antibody (Fig. 2-4B&D, lane 3). These results confirmed that the ~66 kDa protein, pulled down 
with anti-HA, is an NS2 protein that initiates at the HA tag, skips the D1’-A1 intron-encoding 
region tagged with a Strep tag after aa 295, and ends at the C-terminus of the NS1 protein (Fig. 
2-4A, NS2). 
Next, a reverse IP using anti-Strep-conjugated beads was performed with the same 
lysate of the cells transfected with pHBoV1NS1HA296StrepCap. In the precipitated proteins, the NS1 
was always detected at ~100 kDa by all three antibodies (Fig. 2-4E-G, NS1), and an NS protein 
at ~66 kDa was detected with the anti-Strep and anti-NS1C antibodies (Fig. 2-4F&G, lane 3), 
but not with the anti-HA antibody (Fig. 2-4E, lane 3), confirming that the ~66 kDa protein, pulled 
down by the anti-Strep, is NS3 protein that spans the D1’-A1 intron-encoding region, tagged 
with a Strep tag and the C-terminus of the NS1 protein, but is not initiated from the HA tag at the 
N-terminus (Fig. 2-4A, NS3). Protein bands clustered at ~50 kDa were also detected by the 
anti-Strep (Fig. 2-4F, lanes 1&3 and Fig. 2-4C, lane 1, NS3*50). Whether these proteins are 
cleaved or degraded bands of the NS3 or encoded from a new coding sequence remains 
unclear.     
To further understand the NS4 protein expression strategy, we constructed 
pHBoV1NS275FlagCap, in which a Flag tag is inserted after aa 275 of the NS1 protein, 
immediately after a putative AUG at nt 1,171, before the D1’ donor site, and 
pIHBoV1NS622FlagCap, in which a Flag tag is inserted after aa 622 that lies in the A1-D2 small 
exon. We detected an NS protein at ~34 kDa with an anti-Flag antibody in cells transfected with 
either of the plasmids, in addition to the protein bands at ~100 kDa and ~66 kDa (Fig. 2-5, lanes 
2&3). Together with evidence of the detection of the ~34 kDa protein with the anti-NS1C as 
shown in Fig. 2-3&2-4, our results confirm that the ~34 kDa protein is an NS4 protein that  
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Figure 2-5. Detection of the HBoV1 NS4 protein in HEK293 cells transfected with plasmid  
pHBoV1NS275FlagCap or pHBoV1NS622FagCap. 
 293 cells were transfected with pHBoV1NS275FlagCap or pHBoV1NS622FagCap as 
indicated. At two days post-transfection, cells were lysed for Western blotting using an anti-Flag 








initiates at the AUG at aa 275 of the NS1 protein, skips the D1’-A1 intron-encoding region, reads 
through the A1-D2 exon, and extends to the C-terminus of the NS1 (Fig. 2-5, NS4).               
 
Detection of NS2, NS3, and NS4 during HBoV1 replication in HEK293 cells and HBoV1 
infection of HAE-ALI cultures. 
We next sought to detect the NS2, NS3, and NS4 proteins in the HBoV1 reverse 
genetics system and following HBoV1 infection of HAE-ALI cultures. Using an anti-NS1C 
antibody, we detected NS1 at ~100 kDa, a mixed band of NS2 and NS3 at ~66 kDa, and NS4 at 
~34 kDa in HEK293 cells transfected with the replicating pIHBoV1(Fig. 2-6A, lane 3), as well as 
in cells of the HAE-ALI cultures infected with HBoV1 (Fig. 2-6A, lane 5). Using an anti-NS1NL 
antibody, which was raised against aa 1-313 of the NS1, we detected NS1, mixed NS2 and 
NS3, and NS4 proteins at their expected sizes, as indicated, both in transfected and infected 
cells (Fig. 2-6B, lanes 2, 3, and 5). Additionally, a band at ~50 kDa was detected by the anti-
NS1NL (Fig. 2-6B, NS3*50), which is similar to the ~50 kDa protein band detected in the lysate 
of the cells transfected with the pHBoV1NS1HA296StrepCap with the anti-Strep (Fig. 2-4C&F, lane 
1, NS3*50). However, this protein was not detected with an anti-NS1N antibody, which was 
raised against aa 1-120 of the NS1 (Fig. 2-6C, lanes 2, 3&5), suggesting that the ~50 kDa 
protein is likely a derivative of the NS3, named NS3*50.  
Notably, two significant bands grouped at ~35-40 kDa were detected by both the anti-
NS1NL and anti-NS1N antibodies in infected cells but not in transfected cells (Fig. 2-6B&C, 
NS1/2*35-40), suggesting that the NS1/2*35-40 proteins are likely cleaved or degraded proteins 
of the NS1 and NS2 proteins or, perhaps, that they are NS2’ proteins that are highly expressed 
in infected cells. As expected, an anti-NS1N antibody detected both ~100 kDa NS1 and ~66 
kDa NS2 proteins in either transfected or infected cells (Fig. 2-6C, lanes 2, 3 and 5). As noted,  
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Figure 2-6. Detection of HBoV1 NS2, NS3, and NS4 proteins in pIHBoV1-transfected 
HEK293 cells and HBoV1-infected HAE cells.     
 HEK293 cells were transfected with pHBoV1NSCap or pIHBoV1. At two days post-
transfection, cells were lysed. HAE-ALI cultures were infected with HBoV1 at an MOI of 10 
(DRP/cell). At 14 days p.i., infected cells in the ALI cultures were lysed. The lysates of both 
transfection and infection, as indicated, were then analyzed by Western-blot using anti-NS1C 
(A), anti-NS1NL (B), and anti-NS1N (C) antibodies, respectively. The identities of detected 








NS1-70 was detected at a higher level in infected cells than in transfected cells (Fig. 2-6B&C, 
lane 5 vs. lanes 2&3). This result may suggest a potential function of the NS1-70 during 
infection. NS4 was clearly detected at ~34 kDa by the anti-NS1C and anti-NS1NL antibodies 
(Fig. 2-6A&B, lane 2, 3&5), but not by the anti-NS1N (Fig. 2-6C, lane 2, 3&5), in both 
transfected and infected cells.   
Taken together, these results confirm the expression of the novel NS2, NS3 and NS4 
proteins in HEK293 cells transfected with the infectious clone and, more importantly, in HAE-ALI 
cells infected with HBoV1. However, only HBoV1 infection demonstrated relatively abundant 
expression of these short version NS proteins (NS1-70, NS1/2*35-40, and NS3*50).        
NS2, NS3, and NS4 proteins are dispensable for efficient viral DNA replication and virion 
production in the HBoV1 reverse genetics system.  
 To investigate the function of the NS2, NS3, and NS4 in HBoV1 replication, we 
constructed pIHBoV1(smA1’) and pIHBoV1(smD1’), knocking out the A1’ and D1’ splice sites, 
respectively, in the context of the infectious clone pIHBoV1 (Fig. 2-7A). Both mutants 
maintained the encoded NS protein sequences. Analyses of total RNA extracted from HEK293 
cells transfected with pIHBoV1(smA1’) or pIHBoV1(smD1’) using RPAs with a homologous 
PA1’D1’ probe confirmed that splicing at the A1’ or D1’ splice site was abolished (data not 
shown). In order to examine the knockout efficiency of the NS3 and NS2, we constructed smA1’ 
and smD1’ mutations in non-replicating plasmids pHBoV1NS1HA65*Cap and 
pHBoV1NS1HA303*Cap, respectively. The smA1’ mutation knocked down NS3 expression nearly 
to the background of the blot and NS4 expression by ~10-fold (Fig. 2-7B, compare lanes 4 to 
3). The smD1’ mutation knocked out both NS2 and NS4 expression (Fig. 2-7B, compare lanes 




Figure 2-7. Analyses of virus production from transfection of mutant HBoV1 infectious 
clones in HEK293 cells.       
(A) Diagrams of pIHBoV1 and its mutants. pIHBoV1(∆IHBo that has a stop codon 
after the NS1 aa 65 (69), and pIHBoV1(smA1’) and  pIHBoV1(smD1’) that knock out the A1’ and 
D1’ splice sites, respectively, are diagramed with transcription, splicing, and polyadenylation 
units.  (B) NS Knockdown efficiency from smA1’ and smD1’ mutations.  HEK293 cells were 
transfected with plasmids with smA1’ and smD1’ mutations in the context of pHBoV1NSCap, as 
indicated. At two days post-transfection, cells were lysed for Western-blotting using anti-NS1C 
antibody. (C-E) Western blot analysis of proteins from infectious clones. HEK293 cells 
were transfected with plasmids as indicated. Cells were harvested and lysed at two days post-
transfection. The lysates were analyzed by Western-blot using anti-NS1C antibody (C) and 
reprobed with anti-NS1NL and anti-β-actin antibodies (D), and using anti-VP antibody (E). The 
identities of detected proteins are shown with arrows at the right of the blot. The asterisk 
indicates a band that likely a cleaved VP or an unknown VP. (F&G) Southern blot analysis of 
viral DNA replication. (F) HEK293 cells were transfected with plasmids as indicated. At 2 days 
post-transfection, cells were harvested for Hirt DNA preparations. The Hirt DNA samples were 
digested with DpnI and analyzed by Southern blot with an HBoV1NSCap probe (16). The 
identities of detected bands are shown. dRF/mRF, double/monomer replicative form, ssDNA, 
single-stranded DNA. (G) Quantification of the RF bands, which were normalized by the DpnI-
digested DNA, from three independent experiments is shown with means and standard 
deviations. (H) Quantification of virus production. HEK293 cells were transfected with 
plasmids as indicated. At 2 days post-transfection, cells were harvested for virus preparation. 
The final virus preparations (2 ml for each) were quantified for DNaseI-resistant particles (DRP) 
using qPCR, and are shown as DRP/µl in a log scale (Y-axis). Means and standard deviations 
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did not produce NS4 (Fig. 2-7C&D, lane 4), and that pIHBoV1(smA1’) decreased NS3*50 
expression nearly to the background level of the blot (Fig. 2-7D, lane 3) and decreased NS4 by 
over 10-fold (Fig. 2-7C, lane 3). All these mutants produced capsid proteins VP1 and VP2 at a 
level similar to that of the wild-type (WT) (Fig. 2-7E), as well as NP1 (data not shown).  
Next, we tested the replication capability of the mutants in HEK293 cells. 
pIHBoV1(smA1’) had an ~2-fold decrease in the production of replicative form (RF) DNA, while 
pIHBoV1(smD1’) replicated as effectively as the WT (Fig. 2-7F&G). We then produced mutant 
viruses ∆NS2(smD1’) and ∆NS3(smA1’) by transfecting HEK293 cells with pIHBoV1(smD1’) 
and pIHBoV1(smA1’), respectively, and  compared viral production against WT. As shown in 
Fig. 2-7H, the WT virus was produced at a total yield of 2 × 1011 DRP (2 ml of 1 × 108 DRP/µl)  
from five 145-mm plates of transfected HEK293 cells, and the mutant ∆NS3 and ∆NS2 viruses 
were also produced efficiently, with only a moderate decrease of 1.7- and 4.5-fold, respectively.  
Collectively, these results indicate that NS2, NS3 and NS4 are dispensable for viral DNA 
replication and for virus production in the 293 cell reverse genetics system.    
 
The HBoV1 NS2, but not the NS3 and NS4, plays an essential role in HBoV1 replication of 
HAE-ALI.  
We finally infected HAE-ALI cultures with the WT, ∆NS2, or ∆NS3 virus. We collected 
progeny virions produced from the apical side of the ALI cultures for a period of 14 days, and 
quantified their titers. At 2 days p.i., we observed an ~10-fold increase in virion release from the 
ALI cultures infected with either WT or mutant viruses (Fig. 2-8A, 2 dpi), confirming that both 
the WT and mutant viruses infected HAE-ALI. ∆NS2 virus lunched an initial infection at 2 days 
p.i., as shown by an 1-log increase of apical virus release (Fig. 2-8A). However, at 2 days p.i, 
∆NS2 virus-infected cultures showed a gradual decrease in apical virus release, which  
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Figure 2-8. Analyses of virus infection of HAE-ALI cultures.       
HAE-ALI cultures were prepared in Transwell inserts, and infected with HBoV1 WT or its 
mutants, respectively, from the apical surface at an MOI of 10 (DRP/cell). (A) Apical virus 
release. At the indicated days p.i., the apical surface was washed with 100 µl of PBS to collect 
released virus. Virion particles (DRP) were quantified by qPCR (y-axis) and plotted to the days 
p.i. as shown. Means and standard deviations are shown. (B-D) Western blot analysis of 
HBoV1-infected HAE cultures. At 14 days p.i., the cells of the infected ALI culture were lysed 
for Western blotting with anti-NS1C (B), anti-NS1NL (C), or anti-VP antibody (D). Blots were 
reprobed for β-actin, and the blot in panel C was further reprobed with an anti-NP1 antibody. 
The identities of detected proteins are shown with arrows at the right of the blot. In panel D, the 
band indicated by an asterisk is likely a cleaved band of VP1 or a new VP.  (E) Southern blot 
analysis of viral DNA replication. At 14 days p.i., the cells of the infected HAE-ALI cultures 
were lysed for Hirt DNA preparation. The Hirt DNA samples were analyzed by Southern blot 
with an HBoV1 NSCap probe, and a mitochondrial (mito) DNA-specific probe (141), 
respectively. Detected mitochondrial DNA was used for normalization of viral DNA 








remained at a level less than 100 DRP/µl after 6 days p.i. (Fig. 2-8A, ∆NS2). On the other hand, 
though ∆NS3 virus-infected cultures produced virions at a level ~10 times lower than that of the 
WT-infected cultures from 3-9 days p.i., they eventually reached a similar level in apical virus 
release (less than 2 times difference) at days 13 and 14 p.i. (Fig. 2-8A, compare ∆NS3 with 
WT).   
At 14 days p.i., we analyzed NS expression of the infected HAE cells. No NS and capsid 
(VP) proteins were detectable in ∆NS2 virus-infected cells (Fig. 2-8B-D, lane 4). ∆NS3 virus-
infected cells expressed NS1, NS2 (Fig. 2-8B&C, lane 3), NS1/2*35-40 (Fig. 2-8C, lane 3), and 
VP (Fig. 2-8D, lane 3), at levels similar to those of the WT counterpart (Fig. 2-8B-D, lane 2), but 
not NS4 (Fig. 2-8B, lane 3) and NS3*50 (Fig. 8C, lane 3). This result echoes NS expression of 
the ∆NS3 parent infectious clone pIHBoV1(smA1’) (Fig. 2-7C&D). Southern blot analysis 
showed that the ∆NS3 virus infection had a decrease in the level of ssDNA but not the mRF 
DNA (Fig. 2-8E, compare lanes 3 to 2), suggesting that the ∆NS3 virus replicates at a level 
similar to the WT in HAE-ALI. We confirmed that there was no obvious viral DNA detected in 
∆NS2 virus-infected cells at 14 days p.i. (Fig. 2-8E, lane 4). Since both the ∆NS2 and ∆NS3 
mutants did not express NS4 (Fig. 2-8B, lanes 3&4), these results suggest that NS2 is 
essential, but NS3 and NS4 are dispensable, to HBoV1 replication in HAE-ALI.   
Further analyses of the infected HAE by immunofluorescence assays showed that ∆NS3 
virus infection caused loss of cilia on the airway epithelium, as shown by staining of β-tubulin 
(Fig. 2-9A, ∆NS3), and redistribution of the tight junction, as shown by staining of ZO-1 (Fig. 2-
9B, ∆NS3), but to a lesser extent than that of the WT virus (Fig. 2-9, WT). This could be due to 
less expressed NS proteins as detected by the anti-NS1C during infection. On the other hand, 
the abortive infection of ∆NS2 virus did not cause any disruption of the tight junction and loss of 
the cilia, as shown by the ZO-1 and β-tubulin staining, respectively (Fig. 2-9, ∆NS2), which is 
consistent with the abortive infection of the ∆NS2 mutant virus.               
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Figure 2-9. Immunofluorescence analysis of the tight junction protein ZO-1 and the cilia 
marker β-tubulin IV of infected HAE-ALI.       
At 14 days p.i., mock-, WT-, ∆NS2-, and ∆NS3-infected HAE-ALI cultures were co-
stained with anti-NS1C and anti-β-tubulin IV (A), or co-stained with anti-NS1C and anti-ZO-1 










In this study, we confirmed that two novel splice sites are used to process HBoV1 pre-
mRNA, which generate mRNA transcripts that are able to translate small NS proteins, NS2, 
NS3, and NS4. We detected NS2, NS3, and NS4 proteins expressed during HBoV1 DNA 
replication in HEK293 cells and HBoV1 infection of HAE-ALI cultures. Although NS2, NS3, and 
NS4 proteins are dispensable for viral DNA replication and virus production in HEK293 cells, 
NS2 plays a critical role in HBoV1 replication in HAE-ALI cultures. Interestingly, NS2, NS3, and 
NS4 proteins contain the predicted domains of origin binding/endonuclease and transactivation, 
helicase and transactivation, and transactivation, respectively, of the NS1 (Fig. 2-10). 
Importantly, different expression patterns of the NS2, NS3, and NS1-70 were found during 
HBoV1 infection of HAE-ALI compared to those in HBoV1 replication in HEK293 cells, 
highlighting the importance of these small NS proteins during HBoV1 infection of human airway 
epithelia.         
Expression strategy of Bocaparvovirus NS proteins.  
NS1, or Rep78/68 in adeno-associated virus (AAV), is a multifunctional protein that has 
site-specific origin DNA binding, endonuclease, ATPase, and helicase activities (Fig. 2-10, NS1) 
(35,62). It is expressed from viral mRNAs transcribed from the promoter near the left end of the 
genome, which are either unspliced, or spliced at the small intron that lies in the middle of the 
genome (123). HBoV1 uses a strategy similar to that of the AAV2 Rep78/68 proteins (123) to 
express NS1 and NS1-70 from spliced and unspliced mRNAs, respectively, of the pre-mRNA 
transcribed from the P5 promoter. However, BPV and MVC, also members of the genus 
Bocaparvovirus, express NS1 at sizes of 100 kDa (119) and 84 kDa (144), respectively.            




Figure 2-10. Putative functional domains of HBoV1 NS1, NS2, NS3, NS4 and NS1-70.       
A schematic diagram of the HBoV1 NS1 protein is shown. The HBoV1 NS1 protein 
sequence (GenBank: AFR53039) is aligned with the AAV5 Rep78 (GenBank: AAD13755). N-
terminal origin DNA binding domain (OBD, in red) and helicase domain (in purple) are predicted 
based on structured regions of the AAV5 Rep78 OBD (66) and AAV2 Rep40 helicase domain 
(72). Unaligned regions positioned between the OBD and helicase domains (shown in green) 
are predicted by analogy with AAV and MVM to contain NS oligomerization signals. The C-
terminal region (shown in yellow) is predicted to contain a zinc-binding motif as seen in AAV2 
Rep78 (137), while in MVM this region is highly acidic and serves as a potent transcriptional 
activator (88). The OBD (aa1-271) was initially predicted based on secondary structured and 
unstructured regions of the NS1. Its structure has now been determined (152). Dashed lines in 
the OBD indicate residues that are structured as endonuclease core/DNA binding loop (152), 
and dashed rectangles in the helicase domain indicate Walker boxes (84). 
Domains of the NS2, NS3, NS4, and NS1-70 proteins, deduced from those of the NS1, 
are diagramed in colored blocks with thin lines indicating protein sequence excision due to 








virus replication, one of which is the Bocaparvovirus NP1 (69,145). However, only a few 
parvoviruses express small NS proteins that share the amino acid sequences at the N-terminus 
of the NS1. A minute virus of mice (MVM) mRNA excised the large intron, spanned a large 
portion of the NS1-encoding region, expresses NS2, and, thus, NS2 shares only 85 aa with the 
NS1 at the N-terminus (37,123). The NS2 and NS3 proteins of Aleutian mink disease virus 
(AMDV) are expressed by a strategy similar to that of the MVM NS2 (70). They share 60 aa with 
the AMDV NS1 at the C-terminus. Thus, the HBoV1 NS2 is unique in that it shares aa 1-288 
with the NS1, which contains the entire origin DNA binding/endonuclease domain (1-271 aa) of 
the NS1 (152) (Fig. 2-10, NS2). The NS2 also contains the C-terminal aa 598-781 of the NS1. 
Of note, Bocaparvovirus MVC uses the same strategy to express NS1~66kd (144), which is 
equivalent to the HBoV1 NS2. In BPV, we have previously proposed a viral mRNA that has the 
potential to express such an NS2 protein (119), but its expression has not been confirmed yet. 
Altogether, our results suggest that NS2 expression is a common feature among members of 
the genus Bocaparvovirus. 
Small NS proteins, like the HBoV1 NS3, that share the helicase activity domain with the 
NS1 have been identified in viruses of the genus Dependoparvovirus, i.e., AAV Rep52/40 (123) 
and goose parvovirus (GPV) Rep2 (120). But AAV Rep52/40 are expressed from mRNAs that 
are transcribed from an independent P19 promoter in the middle of the Rep78-encoding region 
(123,129). GPV Rep2 is expressed from an mRNA that excises the 1D-1A intron lying in the 
Rep1-encoding region (90,120). Notably, we previously identified a Bocaparvovirus BPV R3 
mRNA that excises an intron (D1-1A1) encoding N-terminal aa 1-282 of the NS1, and a small 
NS protein (BPV NS2) is proposed to be expressed from this mRNA at ~45 kDa (119). In fact, 
multiple NS bands centering at ~45 kDa were detected in BPV-infected cell lysates following 
immunoprecipitation using convalescent-phase sera from BPV-infected calves (87), these may 
be candidates of the BPV NS2 protein. Therefore, like the GPV Rep2 and BPV NS2, the HBoV1 
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NS3 is expressed from the viral mRNA that excises the D1-A1’ intron encoding the origin 
binding domain (aa 1-274) (Fig. 2-10). However, such an expression strategy of NS3 has not 
been identified during MVC infection (144).           
HBoV1 NS4 is expressed from a viral mRNA that has never been identified in 
expression of any parvovirus. The mRNA excises multiple introns (the D1-A1’, D1’-A1, and D2-
A2). NS4 largely contains the C-terminus (aa 598-781) of the NS1 (Fig. 2-10). Currently under 
investigation is whether, in the genus Bocaparvovirus, the NS4 protein expression is conserved 
in MVC and BPV infections.   
  
Functions of the small NS proteins. 
 Our results suggest that HBoV1 NS2 is essential to virus replication in HAE-ALI but not 
to viral DNA replication in 293 cells. The function of the NS2 seems cell-type dependent, like 
that of the MVM NS2, which is not essential for MVM replication in transformed human cell 
lines, but is required for MVM infection in murine cells (110,126). The HBoV1 NS2 harbors the 
whole origin DNA binding domain with endonuclease activity (Fig. 2-10, NS2). Considering 
HBoV1 replicates in differentiated/polarized HAE cells that are out of cell cycle (G0 phase) 
(45,69), we speculate that the endonuclease feature of the NS2 may be required for HBoV1 
DNA replication in non-dividing cells. The function of the MVC counterpart (NS1~66kd) in MVC 
replication is not yet understood (144).   
HBoV1 NS3 is dispensable for virus DNA replication and progeny virus production in 293 
cells, as well as in infection of the HAE-ALI. These results suggest that NS3 is not required for 
viral genome packaging, in contrast to the AAV Rep52/40 that are involved in packaging single-
stranded viral genomes into capsid structures (136), which is mediated by their helicase 
activities (83). Since the ∆NS3 mutant virus expresses little NS4, we believe that the NS4 is also 
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not essential to virus replication and production in HAE-ALI, however, we cannot rule out 
functions of the NS3 and NS4 that may modulate host cell innate immune response during 
infection. Obviously, the function of NS3 and NS4 in the host innate immunity response to 
HBoV1 infection of HAE-ALI warrants further investigation.    
 
NS1-70 and other small NS proteins that terminate at a stop codon in mRNAs retaining 
the D2-A2 intron.  
NS1-70 was expressed at a higher level during virus infection of HAE-ALI than in 
pIHBoV1-transfected 293 cells. NS1/2*35-40 were expressed at a relatively higher level than 
NS1-4 during infection, but the NS1/2*35-40 are not expressed in cells transfected with the 
infectious or non-replicating plasmids. These differences between transfection and infection are 
not understood, but may be due to differences in the types of host cells, or to the cell 
differentiation status between the dividing HEK293 cells and non-dividing HAE cells. The 
NS1/2*35-40 are unlikely to be NS2’ proteins (Fig. 2-2, NS2’), since they were still expressed 
from infection of a mutant virus that bears the intron D2-A2 deletion (data not shown). Similarly, 
the NS3*50 was expressed in HEK293 cells transfected with a mutant infectious clone that has 
the D2-A2 intron deleted, indicating that the NS3*50 is not the NS3’ protein (Fig. 2-2, NS3’). We 
speculate that NS1/2*35-40 and NS3*50 are specifically cleaved products of the NS1/2 and 
NS3 proteins. Further studies are required to investigate the nature of the NS1/2*35-40 and 
NS3*50 proteins.    
 The NS1-70 contains the origin DNA binding/endonuclease and helicase domains of the 
NS1 but without the C-terminus (Fig. 2-10, NS1-70). A mutant infectious clone that expresses 
only the NS1-70 still replicates in 293 cells, but to an extent ~10 times less than of the WT (data 
not shown), suggesting that the C-terminus of the NS1 plays a helper role in HBoV1 DNA 
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replication. Although NS2’ was detectable in transfected cells (Fig. 2-3A, lane 3), NS2’ and 
NS3’ proteins were not obviously detected in infected cells in our study, suggesting that NS4’ is 
not expressed during infection.  
 In contrast to the acute infection of most other autonomous parvoviruses, HBoV1 infection is 
persistent, with the virus replicating in non-dividing airway cells. Taken together, our results 
support the hypothesis that the NS2-4, NS1-70, NS1/2*35-40 and NS3*50 are required for the 
virus to balance replication and host cell death during infection of human airway epithelia. The 
creation of replication defective HBoV1 mutants may have utility in vaccine development for this 




Chapter III:  
Analysis of the Cis and Trans Requirements for DNA Replication at the Right End Hairpin 




Parvoviruses are single-stranded DNA viruses that use the palindromic structures at the 
ends of the viral genome for their replication. The mechanism of parvovirus replication has been 
studied mostly in Dependoparvovirus adeno-associated virus 2 (AAV2) and Protoparvovirus 
minute virus of mice (MVM). Here, we used human bocavirus 1 (HBoV1) to understand the 
replication mechanism of Bocaparvovirus. HBoV1 is pathogenic to humans, causing acute 
respiratory tract infections, especially in young children under 2 years old. By using the duplex 
replicative form of the HBoV1 genome in human embryonic kidney (HEK) 293 cells, we 
identified the HBoV1 minimal replication origin at the right-end hairpin (OriR). Mutagenesis 
analyses confirmed the putative NS1 binding and nicking sites within the OriR. Of note, unlike 
the large non-structural protein (Rep78/68 or NS1) of other parvoviruses, HBoV1 NS1 did not 
specifically bind OriR in vitro, indicating that other viral and cellular components or NS1 
oligomerization are required for the NS1 binding to the OriR. In vivo studies demonstrated that 
residues responsible for NS1 binding and nicking are within the origin-binding domain. Further 
analysis identified that the small non-structural protein NP1 is required for HBoV1 DNA 
replication at OriR. The NP1 and other viral non-structural proteins (NS1-4) colocalized within 
the viral DNA replication centers in both OriR-transfected cells and virus-infected cells, 
highlighting a direct involvement of the NP1 in viral DNA replication at OriR. Overall, our study 
revealed characteristics of HBoV1 DNA replication at OriR, suggesting novel characteristics of 






Human bocavirus 1 (HBoV1) is a recently identified respiratory virus associated with 
acute respiratory tract infections in young children (2,13,50,59,61,73,74,104,132). HBoV1 
belongs to the Bocaparvovirus genus within the Parvoviridae (3,28) family. Other species in the 
Bocaparvovirus genus include minute virus of canines (MVC), bovine parvovirus 1 (BPV1), 
porcine bocavirus, and gorilla bocavirus (18,28,77,119,145).  
A unique feature of bocaparvoviruses, differed from other parvoviruses, is that they 
express the small nuclear phosphoprotein NP1 from an open-reading frame (ORF) located in 
the middle of the genome (16,119,145). NP1 is a non-structural protein and is indispensable for 
viral DNA replication (69,145). The role of the NP1 proteins of HBoV1 and BPV1 in viral DNA 
replication is conserved to that of MVC, and they are exchangeable in supporting MVC DNA 
replication (145). While the mechanism defining how NP1 facilitates bocaparvovirus DNA 
replication remains largely unknown, it has been revealed that NP1 plays an important role in 
processing viral precursor mRNA (pre-mRNA) to matured viral mRNA polyadenylated at the 
distal polyadenylation site, and therefore is important for capsid protein expression 
(53,143,173). In addition, HBoV1 holds unique features in the genus Bocaparvovirus: it naturally 
replicates in non-dividing/polarized human airway epithelial cells, and the replication is 
dependent on the cellular DNA damage and repair machinery (41). Upon transfection, the 
duplex replicative form genome (RF DNA) of HBoV1 replicates in human embryonic kidney 
(HEK) 293 cells and produces infectious progeny virions (69). Aside from the NP1, HBoV1 
expresses two large non-structural proteins, NS1 and NS1-70 (an isoform of the NS1), and 
three other small nonstructural proteins, NS2, NS3, and NS4 (134). They share a C-terminus of 
144 amino acids (aa). NS2 is indispensable for viral replication during infection of polarized 
human airway epithelial cells (134), whereas NS2-4 proteins are dispensable for viral DNA 
replication in HEK293 cells. NS1-70 is expressed at very low level in HEK293 cells transfected 
with the duplex HBoV1 genome, compared to that during HBoV1 infection of differentiated 
human airway epithelial cells (134).   
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Parvovirus replication generates monomer and dimer replicative form DNA (mRF and 
dRF DNA, respectively) intermediates via a unidirectional strand-displacement mechanism, from 
which the ends of progeny genomes are excised by viral replication initiator protein Rep78/68 or 
NS1 (10,35,164). For homotelomeric parvoviruses (e.g., adeno-associated virus [AAV]), in 
which the two genomic termini are inverted in sequence and identical in structure, the replication 
process is symmetrical. The tip of the T structure formed on the termini is critical for Rep78/68 
to nick the replication origin (128). For heterotelomeric autonomous parvoviruses (e.g., MVM 
and HBoV1), in which the two genomic termini are dissimilar, the 3’ end (left-end) hairpin (LEH) 
structure of the negative sense single stranded DNA (ssDNA) viral genome that has a 
replication origin is critical to progress the replication intermediates and to produce the ssDNA 
genome for progeny virion production, and the 5’ end right-end hairpin (REH) structure contains 
another replication origin that is required to replicate viral RF DNA (35). In MVM, the cruciform 
structure at REH is required for RF DNA replication (30). As most of the bocaparvovirus 
genome are negative in sense (145), we also termed the 3’ end of the HBoV1 genome as LEH, 
and the 5’ end as REH, similar to those in MVM. The HBoV1 LEH and REH also have disparity 
sequences and structures.         
At either hairpin end of both homotelomeric and heterotelomeric viruses, the replication 
origin contains Rep78/68 or NS1 binding elements (RBEs/NSBEs) and a nicking site which is 
recognized and nicked by Rep78/68 or NS1 (30,33,36,128). Replication at the origins of both 
termini follows so-called “rolling hairpin replication model” and undergoes a serial of replicative 
intermediates (37,129). Rep78/68 or NS1 binds to RBEs/NSBEs in the origin, executes its 
endonuclease activity, nicks the 5’-3’ single strand, and free up a hydroxyl (OH) group at the 3’ 
end which functions as a primer for viral DNA synthesis by cellular DNA polymerases. The 
binding and nicking properties characterized by in vivo or in vitro studies suggest that RBE or 
NSBE is several tetra-nucleotide repeats, which are directly recognized by the origin binding 
domain (OBD) of the Rep78/68 or NS1. The nicking site is normally 7-17-nt (nucleotide) ahead 
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of the RBE or NSBE at the 5’ end. The genome structure of HBoV1 is unique among these 
heterotelomeric parvoviruses. The LEH forms a rabbit-ear structure of 140-nt with mismatched 
nucleotides (“bubbles”) inside, and the REH consists of a perfect palindromic sequence of 200-
nt in length (69). Of note, the REH of two other bocaparvoviruses, MVC and BPV1, are able to 
form a cruciform structure (145).    
Because of the unique REH structure of the HBoV1 genome, we sought to define the 
minimal requirements for HBoV1 DNA replication at the REH both in cis and in trans using the 
duplex HBoV1 genome in HEK293 cells. We identified a 46-nt minimal replication origin at the 
REH of HBoV1 (OriR), which contains a nicking site and unconventional NSBEs. In addition, we 
uncovered new properties of nonstructural proteins NS1 and NP1 during viral DNA replication at 
the OriR.   
 
Materials and Methods: 
 
Cell culture.  
 HEK293 cells (CRL-1573, ATCC) were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% fetal calf serum (FCS). Cells were incubated at 37°C with 5% CO2. HEK 
293F cells (Life Technologies/Thermo Fisher Scientific Inc, Carlsbad, CA) were cultured in 
suspension in Freestyle™ 293 medium (Life Technologies) at 37°C with 8% CO2. 
Primary human airway epithelium cultured at an air-liquid interface (HAE-ALI) was 
generated and cultured as previously described (41,69). HAE-ALI cultures that had a 
transepithelial electrical resistance (TEER) of >1000 Ω·cm2 were selected to use in this study.  
   
Plasmid DNA construction. 
(i) pIHBoV1-based constructs: The parent HBoV1 infectious clone (pIHBoV1) has 
been described previously (69). The LEH-deleted plasmid pIHBoV1(LEH-) was constructed by 
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deleting the HBoV1 genome sequence of nt 1-140 in pIHBoV1. pIHBoV1(NS1-) and 
pIHBoV1(NP1-), which have the NS1 and NP1 ORFs, respectively, early terminated, and 
pIHBoV1(VP1/3-) that has both the capsid proteins VP1 and VP3 ORFs early terminated, were 
previously described (69). pIHBoV1(REH-), the REH-deleted plasmid, was constructed by 
deleting the HBoV1 sequence of nt 5,303-5,543 in pIHBoV1. pIHBoV1(LEH-VP1/3-) was 
constructed by deleting LEH and early terminating VP1 and VP3 ORFs. Based on the 
pIHBoV1(LEH-VP1/3-), an Xba I was inserted at nt 5,344 to construct REH-truncated mutants 
p∆REH1-24, which are diagrammed in Fig. 3-2. pIHBoV1(3’NCR-), the 3’ noncoding region (3’ 
NCR)-deleted plasmid, was constructed by deleting the HBoV1 sequence of nt 5,221-5,291 in 
pIHBoV1. pIHBoV1(VP-) was constructed by deleting the HBoV1 sequence of nt 3,380-5,119 in 
pIHBoV1. 
(ii) pHBoV1Ori and pHBoV1Ori-based constructs: p∆REH21 was renamed 
pHBoV1Ori that has the minimal replication origin at the REH (OriR) of nt 5,357-5,402.  
pHBoV1λ200Ori, pHBoV1λ400Ori, and pHBoV1λ1000Ori were constructed by inserting 
Lambda (λ) DNA sequences of 200 bp (nt 10,030-10,230), 400 bp (nt 10,030-10,430), and 
1,000 bp (nt 10,030-11,030), respectively, in front of the OriR in pHBoV1Ori.  
pHBoV1(NS1-)Ori and pHBoV1(NP1-)Ori were constructed by early terminating the NS1 
and NP1 ORFs, respectively, in pHBoV1Ori using strategies described previously (69). 
 pNS1m13QOri (Mut Q), pNS1m54PHP56Ori (Mut P), pNS1m123EGL125Ori (Mut E), 
pNS1m115HCH117Ori (Mut Endo), pNS1m127KR128Ori (Mut K), and pNS1m193RR194Ori (Mut R) 
were constructed by mutating the amino acids as indicated by the positions to alanine(s) in the 
context of pHBoV1Ori. They are diagrammed in Fig. 3-9.    
pNSBEm1-8 and pTRSm1-7 plasmids were constructed by introducing various 
mutations in the putative NSBEs and nicking site of the OriR, respectively, in pHBoV1Ori. These 
plasmids are diagrammed in Fig. 3-7A and Fig. 3-8A, respectively, with mutations shown.   
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 (iii) HBoV1 NS1 and parvovirus B19 (B19V) NS1-expressing plasmids: HBoV1 and 
B19V NS1 coding sequences were optimized for mammalian cell expression at Integrated DNA 
Technologies, Inc. (IDT, Coralville, IA), tagged with a Flag tag at the C-terminus, and were 
cloned in pCI expression vector (Promega, Madison, WI), resulting in pOptHBoV1NS1 and 
pOptB19VNS1.   
All nucleotide numbers of HBoV1 and Lambda (λ) DNA are referred to as Genbank 
accession no. JQ923422 and NC_001416, respectively, unless otherwise specified.  
  
In vivo DNA replication analysis.  
HEK293 cells were seeded in 6 well plates or 60mm dishes one day before transfection. 
At a confluence of 70%, cells were transfected with LipoD293 reagent (SignaGen, Gaithersburg, 
MD) or Lipofactamine and Plus reagent (Life Technologies) following the manufacturers’ 
instructions. 
Low-molecular weight DNA (Hirt DNA) was extracted and digested with Dpn I, followed 
by Southern blotting. These steps were performed exactly as previously described (63). After 
hybridization, the membrane was exposed to a phosphor screen. The screen was then scanned 
on a phosphor imager (GE Typhoon FLA 9000, Fuji). The developed image was processed and 
analyzed using ImageQuant TL8.1 software (GE Healthcare, Marlborough, MA). 
 
BrdU incorporation, immunofluorescence (IF) assay, and proximity ligation assay (PLA). 
For virus-infected differentiated airway epithelial cells, we treated the infected HAE-ALI 
treated with 5 mM EDTA for 5 mins and then trypsinized the infected cells off the insert. We 
resuspended ~1 × 105 cells in 1 ml of the ALI medium with BrdU (Sigma, St Louis, MO) at 30 
μM for 20 min. For transfected HEK293 cells, at two days post-transfection, the cells were 
incubated with BrdU for 30 min, followed a previously published method (99). Then, the labeled 
cells were cytospun onto slides for IF analysis.   
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 IF analysis was performed following a method described previously (99,100), with 
antibodies against proteins or BrdU as indicated in Fig. 3-5. Confocal images were taken with 
an Eclipse C1 Plus confocal microscope (Nikon) controlled by Nikon EZ-C1 software. DAPI 
(4’,6-diamidino-2-phenylindole) was used to stain the nucleus. 
The Duolink PLA Kit (Sigma) was used to perform PLA according to the manufacturer’s 
instructions as previously described (41). 
 
Antibody production and antibodies used. 
HBoV1 anti-NS1C antibody was produced as previously described (16), which reacts 
with all four NS proteins (NS1-4) (134). All animal procedures were approved by the Institutional 
Animal Care and Use Committee of the University of Kansas Medical Center. Rabbit anti-
HBoV1 NP1 antibody (106) was a kind gift from Dr. Peter Tattersall at Yale University. Rabbit 
anti-BrdU (cat no.: 600-401-C29, Rockland, Limerick, PA), mouse anti-Flag monoclonal 
antibody (Sigma, St. Louis, MO), and secondary antibodies for IF assay (Jackson 
ImmunoResearch Inc., West Grove, PA) were purchased. 
  
Rapid amplification of the 3’ end of the nicked DNA.  
DNA tailing reaction was performed using terminal transferase (NEB, Ipswich, MA). 
Basically, the reaction was composed of 5.0 μl of 2.5 mM CoCl2, 1 μl of 10-50 times diluted Hirt 
DNA (from ~500 cells), 0.5 μl of 10 mM dATP, 0.5 μl of Terminal Transferase (20 units/μl), and 
deionized H2O in a final volume of 50 μl. The reaction was incubated at 37°C for 30 min. Two μl 
of the product was used as template for PCR amplification using forward primer (5’-CTG TCT 
AGA ATG ATC AAT GTA TGC CAG-3’, nt 5,121 to nt 5,138) and reverse primer (5’- is CAC 
GGA TCC TTT TTT TTT TTT TTT T-3’). Amplified fragments were cloned into pcDNA3 (Life 




Protein expression and purification.   
One 500 ml suspension culture of 293F cells (106 cells/ml) was transfected with pOpti-
HBoV1NS1 or pOptiB19VNS1, using TransIT-PRO® following the manufacturer’s instructions. 
At 3 days post-transfection, cells were lysed in L buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 
mM EDTA, 1% Triton-X100, 1mM dithiothreitol (DTT), 5mM ATP, and 5 mM MgCl2) 
supplemented with protease inhibitors (Cat. No: S8820, Sigma). Crude lysate was sonicated for 
3 mins at a frequency of 15 sec/25 sec on/off, pulse 70% by the VCX130 sonicator (Sonics & 
Materials Inc., Newtown, CT). The lysate was then centrifuged at 10,000 rpm for 15 mins and 
filtrated through a 0.2 μm filter. The filtered lysate was incubated with 1 ml of PBS (phosphate 
buffered saline, pH7.4)-prewashed anti-Flag G1 affinity resin (Genscript, Piscataway, NJ) at 4°C 
for at least 1 hr. Then, the beads were washed with washing buffer (50 mM Tris, pH7.4, 500 mM 
NaCl, 0.05% Triton-X100, and protease inhibitors) 5 times of resin volume, and were eluted with 
3 × Flag peptide (APExBIO, Houston, TX) at a concentration of 200 µg/ml. Finally, the eluted 
protein was dialyzed against PBS twice and against binding buffer (B buffer: 20 mM Tris-HCl, 
pH 8.0, 125 mM NaCl, 10% glycerol, 1% NP-40, 5 mM DTT, and protease inhibitors) once, and 
was concentrated 10 times using polyethylene glycol 6000 (PEG). The concentrated protein 
was quantified, aliquoted, and stored at -80°C. 
 
Gel shift assay.  
Gel shift assay was performed essentially following a published method (24). Duplex 
DNA probe was generated by annealing complementary oligos, at a concentration of 45 µM, in 
an annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA) after boiling for 5 mins. The 
dsDNA probe was cleaned using a G-50 column (GE Healthcare). Duplex DNA probes are 
HBoV1 OriR (Fig. 3-2F), HBoV1 OriR-mut (5’-CGC GAA ACT CTA TAT CTT TTA ATG GCA 
GAA TTC AGC ACA TGC GCC A-3’), B19V Ori (5’-GCC GCC GGT CGC CGC CGG TAG GCG 
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GGA CTT CCG GTA CA-3’) (151), and B19V Ori-mut (5’-AGC TAT TGG TCG CTA TTG GTA 
GGC GGG ACT-3’ (151).  
One µl of the duplex DNA probe was labeled with γ-p32-ATP using T4 polynucleotide 
(NEB) following the manufacturer’s instructions. The binding reaction consisted of 8 µl of 2.5 × B 
buffer (see above), 2 µl of diluted duplex DNA probe (at 1:10,000), with/without 2 µl of purified 
protein (300 ng/µl), 2 µl of unlabeled (cold) probe at a concentration (ratio) specified in Fig. 3-
10, and dH2O to a total volume of 20 µl. In some reactions, poly[d(I-C)] was added at a final 
concentration of 2 μg/ml. The reactions were incubated on ice for 20 mins, loaded directly into a 
pre-run 5% non-denaturing polyacrylamide gel, and electrophoresed for 45 mins at 100 volts. 
Finally, the acrylamide gel was dried by vacuum at 70°C and exposed to a phosphor screen.  
 
Nuclear extract (NE) preparation.  
Nuclear extraction was performed following a method described previously (44). 
HEK293 cells of one dish of 100 mm were transfected with pOptiHBoV1NS1 or pOptiB19VNS1. 
At 2 days post-transfection, cells were collected, washed with ice-cold PBS, and pelleted. The 
cell pellet was lysed in five volumes of L buffer (10 mM HEPES, pH7.5, 10mM KCl, 0.1 mM 
EDTA, 1 mM DTT, 0.5% NP-40, and protease inhibitors). The lysate was vortexed and 
centrifuged at 500 g for 5 mins at 4°C. The pelleted nuclei were washed 3 times with 1 ml W 
buffer (10 mM HEPES, pH 7.5, 10mM KCl, 0.1 mM EDTA, 1 mM DTT, and protease inhibitors). 
Nuclei were resuspended in 0.25 ml of NE buffer (20 mM HEPES, pH 7.5, 420 mM NaCl, 1 mM 
EDTA, 1 mM DTT, 25% glycerol (v/v), and protease inhibitors), and were incubated on ice for 30 
mins. Finally, nuclear extract was obtained as the supernatant by centrifuging the lysed nuclei at 
12,000 g for 10 mins at 4°C, and was adjusted the NaCl concentration to 100 mM using B1 
buffer (=buffer NE without NaCl).   
 
 Pull-down assay.   
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Biotin-labeled probe was generated by annealing two complementary oligos, in which 
one oligo was biotinylated, at a concentration of 5 µM. Annealed dsDNA probe was desalted 
using a G-50 column. Streptavidin-conjugated beads (Gold Biotechnology, St. Louis, MO) were 
prewashed following the manufacturer’s instructions. Binding reaction consisted of 200 µl of 2.5 
× B buffer with poly[d(I-C)], 100 µl of nuclear extract (~5 μg/ml), 1 µl of biotinylated probe, 
with/without unlabeled probe, and dH2O in a total volume of 0.5 ml. The reactions were rotated 
at 4ºC overnight, and were pelleted by centrifugation at 1,000 g for 3 mins. The pellet was then 
washed 3 times with cold PBS before adding loading buffer. The samples were boiled for 5 mins 
and analyzed by SDS-polyacrylamide gel electrophoresis, followed by Western blotting.  
 
Immunoprecipitation (IP) assay.  
              HEK293 cells cultured in one 60mm dish were mock-transfected or transfected with 
plasmids. At 2 days post-transfection, the cells were washed and lysed with 300 µl 
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-
40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitors) with constant agitation for 
30 mins at 4ºC. The cell lysates were centrifuged at 14,000 g for 3 mins at 4ºC, and the 
supernatant was collected. The rest supernatant (~220 μl) was pre-incubated with 40 µl of 
normal rat serum, 30 μl of prewashed protein A/G bead (ThermoFisher), and 2 µl of benzonase 
(ThermoFisher) for 3 hr at 4ºC with rotation. After preclearing, the supernatant was equally 
divided for incubation with either 2 µl of normal rat IgG (0.4 mg/ml, Santa Cruz, Dallas, TX) or 
20 µl of rat antisera, 30 µl of protein A/G beads, and 300 µl of RIPA buffer at 4ºC overnight. 
Finally, the protein A/G beads were pelleted down and washed 3 times with ice cold PBS before 
mixing with loading dye for Western blotting.  
 
Results 
Identification of viral elements required in cis or in trans for HBoV1 replication. 
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To understand the DNA replication mechanism of HBoV1, we first delineated viral DNA 
signals and viral proteins that are required for viral DNA replication. As diagrammed in Fig. 3-
1A, the HBoV1 genome contains four noncoding sequences (LEH, P5 promoter region, 3’ NCR, 
REH) and three ORFs that encode NS1-4, NP1, and VP1-3 proteins, respectively (134,173). 
The 3’ non-coding region (3’ NCR) contains a sequence of ~200 nts between the 
polyadenylation signal of VP mRNA and the REH. To dissect the minimal requirements for viral 
DNA replication, we carried out sequential deletions of the noncoding regions and early 
termination of the ORFs in the context of pIHBoV1. Southern blotting results showed a 
representative pattern of HBoV1 DNA replication including the Dpn I-digestion resistant bands: 
viral single-strand DNA (ssDNA, genome size), viral RF DNA and double RF (dRF) DNA, and 
plasmid-replicated DNA (Fig. 3-1B, lane 1). The results suggested that, without the LEH 
sequence, pIHBoV1(LEH-) still replicated but failed to excise the HBoV1 RF DNA out of the 
plasmid (Fig. 3-1B, lane 2). VP1/3-knockout plasmid pIHBoV1(VP1/3-) replicated better than 
the parent pIHBoV1 (Fig. 3-1B, lanes 5 vs 1). As noted, ssDNA was only produced from the 
transfections of pIHBoV1 and pIHBoV1(VP1/3-). However, pIHBoV1(NS1-), pIHBoV1(3’NCR-), 
and pIHBoV1(REH-) did not replicate (Fig. 3-1B, lanes 3, 6 and 7, respectively), and 
pIHBoV1(NP1-) replicated very poorly (Fig. 3-1B, lane 4), suggesting that the sequence at the 
3’ end, including REH and 3’ NCR, and expression of NS1 and NP1 proteins were apparently 
critical to HBoV1 DNA replication. pIHBoV1(VP-), in which the VP encoding ORFs were largely 
deleted, replicated as well as the pIHBoV1 (Fig. 3-1C, lane 2).  
Taken together, our results suggest that REH and 3’ NCR are largely responsible for 
HBoV1 DNA replication as cis-acting elements, while NS1 and NP1 serve trans-acting functions 
(134). In the following experiments, we used both LEH deletion and the VP1/3 knockout  
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Figure 3-1. Identification of the cis-acting sequences and trans-acting proteins required 
for HBoV1 replication. 
(A) Diagram of HBoV1 genome and mutants. HBoV1 genome is shown as a negative 
sense ssDNA. Sequentially from left to right, the functional elements are left-end hairpin (LEH, 
3’ end), P5 promoter, NS-coding region, NP1-coding region, VP-coding region, 3’ noncoding 
region (3’ NCR), and the right-end hairpin (REH, 5’ end). The wild-type infectious clone is shown 
as duplex form DNA (dsDNA). Non-coding sequences LEH, 3’ NCR, and REH were deleted as 
described in Materials and Methods. The ORF of NS, NP1, or VP was terminated as described 
in Materials and Methods. Dotted lines indicate sequence deletion, vertical bars indicate 
nucleotide mutations. (B&C) Southern blot analysis. The wild-type infectious clone (pIHBoV1) 
or the indicated mutants were transfected into HEK293 cells. At 2 days post transfection, low 
molecular weight (Hirt) DNA was extracted and applied for Southern blotting after Dpn I 
digestion. One hundred and twenty ng of pIHBoV1 digested with Dpn I at the same condition as 
Hirt DNA samples was used as Dpn I digestion control (Dpn I-Dig. Ctrl). RF, replicative form 
DNA intermediate, dRF, double RF DNA intermediate, ssDNA, single-stranded DNA. An arrow 
in panel A and an asterisks panel B indicate replicated DNA from the entire HBoV1 DNA-






HBoV1 plasmid, pIHBoV1(LEH-VP1/3-), for further characterization of HBoV1 DNA replication 
at REH.     
 
Identification of an HBoV1 right-end minimal replication origin (OriR). 
For DNA replication of either dependoparvovirus or autonomous parvovirus, RBEs or 
NSBEs and a nicking site are requisite at the end palindromic hairpinned sequence 
(30,33,36,128). These two cis-signals are necessary for Rep78/68 or NS1 to recognize the 
replication origin and perform strand-specific nicking, and to initiate DNA replication. To identify 
the minimal replication-requisite sequence on REH, we constructed a serial of truncation 
mutants of the REH on the base of plHBoV1(LEH-VP1/3-) (Fig. 3-2A). We used linearized 
HBoV1 DNA for in vivo DNA replication analysis, in order to avoid circular plasmid DNA 
replication as that seen from pIHBoV1(LEH-) (Fig. 3-1B, lane 2). The first group of truncations 
contained a progressive deletion from the 3’ end of the REH (Fig. 3-2A, Group I). The results 
showed that the level of viral DNA replication decreased as 3’ end nucleotides of the REH were 
removed (Fig. 3-2B). As there was a clear decrease of viral DNA replication resulting from 
∆REH2 to ∆REH3 HBoV1 DNA (Fig. 3-2B, lanes 3 vs 4), we fixed the right end at nt 5,430 of 
the ∆REH2 HBoV1 DNA, and started progressive truncations from the 5’ end (nt 5,344) (Fig. 3-
2A, Group II). Results of viral DNA replication analysis showed a large decrease in RF DNA 
from ∆REH10 to ∆REH11 (Fig. 3-2C, lanes 3 vs 4). Thus, we determined the 5’ end of the OriR 
to be at nt 5,357, the 5’ end of ∆REH10.  
To define the 3’ end of the OriR more carefully, we performed progressive deletions from 
the 3’ end of ∆REH10 (nt 5,357). DNA replication analysis of the mutants from ∆REH17 and 
∆REH19-24 showed that further deletions of the 3’ end after nt 5,402 (Fig. 3-2D,  
∆REH21/lane 6) significantly decreased the level of RF DNA (Fig. 3-2E). This result defined the 




Figure 3-2. Identification of the minimal replication origin at the REH (OriR). 
(A) Diagram of REH deletion mutants. All REH deletion mutants were constructed 
based on the LEH-deleted and VP1/3-knockout plasmid pIHBoV1(LEH-VP1/3-). Group I 
mutants had deletions at the 3’ end from nt 5,543 to 5,383. Group II mutants shared the 3’ end 
deletion to nt 5,430 and were further deleted at the 5’ end from nt 5,354nt to 5,384. Group III 
mutants shared the 5’ end deletion to nt 5,357 except for ∆REH18, which had a 5’ end at nt 
5,360. The deletion at the 3’ end started from nt 5,410nt to 5,390. (B-D) Southern blot 
analyses. HEK293 cells were transfected with linearized mutant HBoV1 DNAs, and Hirt DNA 
samples were extracted at two days post transfection. DpnI digested Hirt DNA samples were 
applied for Southern blotting. (E) Quantification. Three experiments were repeated for panel D, 
and the RF DNA was quantified in each lane. The level of RF DNA from the wild-type HBoV1 
was set up as 100% (Lane 1) after normalization with the main Dpn I-digested bands. N.S., not 
significant, *, P<0.05, **, P<0.01. (F) Minimal replication origin (OriR). The sequence of the 







deleted at the 5’ end in ∆REH17, to confirm the 5’ end of the OriR. The result showed that 
replication from ∆REH17 was significantly decreased by ~3-fold (Fig. 3-2D, lane 3).  
 Collectively, we defined HBoV1 OriR as a 46-nt DNA of nt 5,357-5,402 (Fig. 3-2F). 
Although these deleted sequences which flank the OriR are dispensable for the replication at 
the OriR, they are required for the maximum DNA replication at the REH. Of note, HBoV1 has a 
long 3’ NCR in front of the OriR. To clarify whether the OriR replicates viral DNA independent of 
the 3’ NCR, we inserted various λ DNA of 0.2, 0.4, and 1.0 kb between the 3’ NCR and the OriR 
in HBoV1Ori DNA (Fig. 3A). DNA replication analysis showed that the OriR conferred viral DNA 
replication regardless of the insertion sizes between the 3’ NCR and OriR, supporting that the 
OriR functions as a template of DNA replication independently of the adjacent 3’ NCR (Fig. 3-
3B).   
 
NP1 colocalized with NS proteins within the viral DNA replication centers, and is required 
for viral DNA replication at OriR. 
 We next checked the trans-acting factors that facilitate viral DNA replication at OriR. We 
constructed NS1 or NP1 knockout plasmids based on pHBoV1Ori, and performed viral DNA 
replication analysis. We observed that, without NS1/2 or NP1 expression, replication at the OriR 
was abolished (Fig. 3-4, lanes 2&3), reflecting that NS1 and NP1 are required for HBoV1 DNA  
replication at the OriR, since NS2 is not required for HBoV1 DNA replication in HEK293 cells 
(134).    
Replication of parvovirus MVM and H-1 takes place in discrete subnuclear 
compartments, where termed autonomous parvovirus-associated replication (APAR) bodies 
(9,38). APAR bodies are active sites of viral DNA replication and contain cellular DNA 
replication factors and parvovirus NS1 (9). We located the APAR bodies using BrdU to pulse 
chase active replicating viral ssDNA (99,100). Similar to other parvoviruses (9,38), the APAR 
bodies of HBoV1 replication showed various patterns in different cells, from foci-like dots  
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Figure 3-3. HBoV1 OriR replicated independent of upstream 3’ NCR.  
(A) Diagram of λ DNA insertion mutants. Based on pHBoV1Ori, 200 bp, 400 bp, or 
1000 bp of λ DNA was inserted between 3’ NCR and REH. (B) Southern blot analysis. 
HEK293 cells were transfected with linearized mutants. At two days post transfection, Hirt DNA 
samples were extracted and digested with Dpn I before they were applied for Southern blotting. 








Figure 3-4. Both NS1 and NP1 are required for DNA replication at OriR.  
HEK293 cells were transfected with HBoV1Ori or its mutants HBoV1(NS1-)Ori and 
HBoV1(NP1-)Ori. Hirt DNA samples were extracted at two days post transfection and were 
digested with Dpn I for Southern blotting. Sixty ng of IHBoV1 digested by DpnI was used as a 







to broad distribution in the nucleus, and colocalized with NS proteins stained with anti-NS1C in 
HEK 293 cells transfected with pHBoV1Ori or pIHBoV1 (Fig. 3-5A, NS/BrdU). Notably, co-
localization patterns of NP1 and BrdU staining were similarly observed as the NS and BrdU co-
staining, suggesting that both NP1 and NS localized within APAR bodies (Fig. 3-5B, 
NP1/BrdU). In support of this hypothesis, NS and NP1 proteins colocalized in the nucleus of 
pHBoV1Ori or pIHBoV1-transfected cells (Fig. 3-5C, NP1/NS). More importantly, in HBoV1-
infected HAE cells, NS and NP1 co-localized well within the BrdU-chased APAR bodies (Fig. 3-
5D-F). To confirm the localization of NP1, we used proximity ligation assay (PLA) to visualize 
interactions of NP1 with BrdU-labeled viral ssDNA or dsDNA/ssDNA intermediates. We 
observed clearly positive fluorescent foci in the nucleus of pHBoV1Ori and pIHBoV1-
transfected, or HBoV1-infected cells stained with anti-NP1 and anti-BrdU antibodies (Fig. 3-5G). 
PLA shows bright signals only if the two molecules localize proximately at a distance of ~20 nm 
(138).   
To explore a direct interaction between NS1 and NP1, we performed 
immunoprecipitation assays. Cells transfected with pHBoV1Ori were lysed and pre-cleared with 
normal rat sera. Pre-clear lysates were immunoprecipitated with control rat IgG or anti-NP1  
serum in the presence of nuclease treatment, and were then evaluated for NS1 by Western 
blotting. Neither NS1, NS2, NS3 nor NS4 were co-immunoprecipitated with NP1 (Fig. 3-6A, 
lanes 6 vs 4). As a control, using an anti-NS1C antibody, all NS proteins could be 
immunoprecipitated (Fig. 3-6B, lanes 3 vs 1). These results suggest that NS1-4 and NP1 
proteins do not directly interact. 
Taken together, these results suggest that either by transfection of pIHBoV1/pHBoV1Ori 
or during viral infection, HBoV1 NS1-4 and NP1 proteins function synergistically in the viral DNA 
replication centers (APAR bodies) but without a direct interaction. More importantly, these 




Figure 5. NS and NP1 co-localized with the BrdU-chased viral DNA replication centers.    
(A-C) Localization of NS, NP1, and BrdU-incorporated HBoV1 DNA in transfected 
cells. HEK 293 cells were transfected with pBB (vector backbone), pIHBoV1, or pHBoV1Ori. At 
two days post transfection, the cells were incorporated with BrdU before being harvested and 
then applied for immunofluorescence staining. Anti-NS1C with anti-BrdU (A), anti-NP1 with anti-
BrdU (B), and anti-NS1C with anti-NP1 were co-stained. (D-F) Localization of NS1, NP1, and 
BrdU incorporated HBoV1 DNA during infection. HAE-ALI cultures were infected by HBoV1 
at an MOI of 10. At 7 days post infection, cells were incorporated with BrdU and applied for 
immunofluorescence analysis. NS, NP1, or BrdU were co-stained in different combinations. (G) 
Interaction of NP1 with BrdU-chased viral DNA. Transfected cells, as indicated, were pulse 
chased with BrdU, and were analyzed by PLA with anti-NP1 and anti-BrdU antibody. DAPI was 








Figure 3- 6. NS and NP1 did not interact directly. 
HEK 293 cells were transfected with pHBoV1Ori or mock transfected. At two days post-
transfection, cells were washed, lysed and pre-cleared with normal rat serum as described in 
the Material and Methods. Pre-cleared lysates were immunoprecipitated with either rat IgG and 
rat anti-NP1 rat serum, respectively (A), or rat IgG and rat anti-NS1C serum, respectively (B). 
Immunoprecipitated proteins were analyzed by Western blotting using an anti-NS1C antibody. 







Identification of the NS1 binding elements (NSBES) and nicking site within OriR. 
The replication origins of parvoviruses harbor multiple binding elements of Rep78/68 or 
NS1 and a specific nicking site (30,33,36,128). Therefore, we next aimed to define the NSBE 
and nicking site by means of mutagenesis. The NSBEs characterized in AAV and MVM by both 
in vivo and in vitro studies are several tetra-nucleotides repeats, which are directly recognized 
by the origin binding domain (OBD) of the AAV Rep68/78 or MVM NS1. Notably, there are no 
identical NSBEs for HBoV1 NS1 binding that can be located in both REH and LEH (69). In 
contrast, we found that similar to the 4 repeats of tri-nucleotides in Galleria mellonella 
densovirus (GmDNV), there are 4 repeats of “TGT” tri-nucleotides “5’-TGT TGT TGT TGT-3’” in 
OriR (Fig. 3-7A) (153).  
We therefore made serial mutations in the “TGT” repeated region in OriR, and performed 
in vivo DNA replication analysis. The results showed that all these mutations of the  
 “TGT” tri-nucleotides significantly decreased DNA replication to various levels under 40% of the 
activity of the wild-type (Fig. 3-7B&C), moreover, the mutation of multiple “TGT” progressively 
disable DNA replication to a greater extent. For example, mutating two “TGT” remained DNA 
replication better than mutating three “TGT” (Fig. 3-7B&C, lanes 1&2 vs lanes 4-7). Mutating all 
four “TGT” decreased DNA replication the most, at level of only 5% of the wild-type (Fig. 3-
7B&C, lane 3). Thus, our results suggest that this “TGT” repeating sequence is likely the HBoV1 
NSBEs.   
The nicking sites of parvoviruses are not conserved (36). In principle, after nicking, the 
Ori reveals transient nicked intermediate (ssDNA breaks) before the free 3’–OH extends by 
DNA polymerase (35). We employed a strategy of rapid amplification of the nicked 3’ end to 
characterize the intermediates of the resolved OriR after NS1 nicking. Using Hirt DNA extracted 
from pIHBoV1- or pHBoV1Ori-transfected cells, we added adenosines to extend the 3’ end with 
polyA residues. With subsequent PCR amplification and cloning, we mapped a few transient 
ending sites in the OriR (Fig. 3-8A). To identify the nicking among these ending sites, we  
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Figure 7. Characterization of the putative NS1 binding element in vivo.  
(A) Diagram of NSBE mutants. The wild-type OriR and mutated sequences of the 
putative NSBE are shown. The putative NSBE include (TGT)4, and the mutants were 
constructed based on various mutations of the “TGT” repeats. Dotted sites represent identical 
nucleotides. (B) Southern blot analysis. HEK293 cells were transfected with linearized wild-
type Ori and NSBE mutants as indicated. Hirt DNA samples were extracted and applied for 
Southern blotting after Dpn I digestion. (C) Quantification. After normalization with Dpn I-
digested bands, the RF DNA bands on blots were quantified. Relative levels to the RF DNA 
from HBoV1Ori (lane 9) are shown with averages and standard deviations from three 








Figure 3-8. Identification of the nicking site within OriR in vivo.  
(A) Diagram of the nicking site mutants. The dynamic nicking site identified by rapid 
amplification of the 3’ end of nicked DNA are indicated by arrows. The sequenced results of 
poly-adenosine starting sites derived from transfection of the HBoV1 full-length genome 
(IHBoV1) and HBoV1Ori are shown with green and black arrowheads, respectively. Mutations at 
seven of these polyA starting sites, as shown, were performed. (B) Southern blot analysis. 
Linearized HBoV1 DNAs were transfected into HEK293 cells. At two days post-transfection, Hirt 
DNA samples were extracted, Dpn I digested, and analyzed by Southern blotting. Sixty ng of 







mutated each site located outside of the NSBEs (Fig. 3-8A). Analysis of in vivo DNA replication 
showed that mutations at either the A or T nucleotide at nt 5,368 or 5,369, but not the mutations 
in other locations, completely abolished viral DNA replication, (Fig. 3-8B, lanes 5&6 vs lanes 1-
4). A mutation at nt 5,373 within the putative nicking motif (5’-CTA TAT CG-3’) also reduced the 
level of RF DNA (Fig. 3-8A, TRSm7, and Fig. 3-8B, lane 7). This result defined the T at nt 
5,369 as the nicking site (5’-CTA/TATCT-3’).   
 
Identification of the key OriR-binding residues in the origin-binding domain (OBD) of the 
HBoV1 NS1.   
We have previously resolved the structure of the HBoV1 OBD, and predicted that NS1 
utilizes two non-structured positively charged loop regions to bind Ori (152). We thus examined 
the binding residues of the NS1 using a mutagenesis approach (Fig. 3-9A). To this end, we 
performed mutations of either amino acids at the positively charged loops (loop K: 127KR128 and 
loop R: 193RR194) or predicted endonuclease activity motif of the NS1 (115HCH117), together with 
three control mutations (Mut Q, P, and E), in the context of HBoV1Ori. Mut Q and Mut P 
mutated the first and the second loops, respectively, of the HBoV1 NS1 OBD structure as 
controls. Mut E control mutated the nearby amino acids (123EGL125) of putative loop K (Fig. 3-
9B). Structures of the mutated NS1 OBD were predicted based on the wild-type NS1 OBD 
(152). Superimposition forms of mutants with wild-type NS1 OBD showed that the mutagenesis 
did not significantly change the structure (Fig. 3-9B). In vivo DNA replication analysis showed 
that mutating either the basic charged loop region (Mut K and Mut R) or the endonuclease core 
(Mut Endo) abolished replication, whereas the three control mutations did not alter DNA 
replication very much (Fig. 3-9C). These data suggest that the two positively charged loops of 
the OBD, as well as the two histidine residues at the predicted endonuclease motif, are required 
for HBoV1 DNA replication, and that the two positively charged loops likely play a significant 
role in the NS1 and OriR binding.   
94 
 
Figure 3-9. Characterization of the Ori binding domain (OBD) of the NS1 in vivo. 
(A) Diagram of NS1 mutants. The NS1 OBD is diagrammed to scale with putative Ori 
binding site and endonuclease activity shown. Based on pHBoV1Ori, OBD mutants that have 
NS1 amino acid mutations at the indicated positions are shown. (B) Superimposition of three 
NS1 OBD mutants with the wild-type NS1 OBD structure. The NS1 OBD structures of Mut K, 
Mut R, and Mut Endo mutants were predicted by the web server ‘I-TASSER’ based on the wild-
type structure (172). The predicted structures of the mutants were individually superimposed 
with wild-type NS1 OBD structure using the web server ‘Superpose 1.0’ (101). The mutated 
amino acid residues in the putative DNA binding loops K and R and the endonuclease activity 
core are labeled with green boxes. (C) Southern blot analysis. Linearized HBoV1 DNAs, as 
indicated, were transfected into HEK293 cells. At two days post-transfection, Hirt DNA samples 
were extracted, digested with Dpn I, and analyzed for DNA replication using Southern blotting. 







HBoV1 NS1 did not specifically bind OriR in vitro.  
To understand the interaction between HBoV1 NS1 and OriR (Fig. 3-2F), we purified 
HBoV1 NS1 (Fig. 3-10A, lane 2) and studied its binding with the OriR in vitro. As a positive 
control for NS1 binding to OriR, B19V NS1 was purified (Fig. 3-10A, lane 1) and carried along in 
parallel.  
We used B19V NS1 binding to B19V Ori as a positive control because B19V also has a 
short Ori of 67-nt (63). Electrophoresis gel shift assay showed that B19V NS1 shifted the B19V 
Ori (Fig. 3-10B, lane 2). This binding is specific because it was competed by excess cold B19V 
Ori but not by excessed cold mutated B19V Ori (Ori-mut) (Fig. 3-10B, lanes 4 vs 6). As a 
negative control, GST protein did not shift the B19V Ori (Fig. 3-10B, lane 7), and the B19V Ori-
mut was not shifted by B19V NS1 (Fig. 3-10B, lanes 8 vs 9). In contrast, however, with the 
same experimental condition of the electrophoresis gel shift assay, HBoV1 NS1 did not bind its 
own OriR specifically (Fig. 3-10C, lane 2). Adding either cold OriR (Fig. 3-10C, lanes 3-5) or 
cold Ori-mut (Fig. 3-10C, lanes 6-8) showed similar negative signals. Of note, we found weak 
non-specific interaction between HBoV1 NS1 and non-specific DNA in the binding buffer without 
poly[d(I-C)] (Fig. 3-10D, lane 2). This non-specific binding was competed either by excessed 
cold HBoV1 OriR (Fig. 3-10D, lanes 3-5) or cold HBoV1 OriR-mut (Fig. 3-10D, lanes 6-8). Thus, 
the gel shift assays suggest that HBoV1 NS1 alone does not bind HBoV1 OriR specifically in 
vitro.   
To further examine the binding property between HBoV1 NS1 and OriR in the presence 
of cellular proteins, we designed a biotin pull-down assay. Nuclear extract prepared from NS1-
transfected HEK 293 cells was used for pull-down by biotin-labeled OriR (Bio-OriR) and 
streptavidin-conjugated beads, and then analyzed by Western blotting. In the experiment with 
B19V Ori, biotinylated B19V Ori (Bio-Ori) pulled down B19V NS1, which was competed by 




Figure 3-10. HBoV1 NS1 alone did not specifically bind the OriR in an in vitro setting.  
(A)  NS1 protein purification. Five µl (15 pmol) of purified HBoV1 NS1 (lane 1) and 
B19V NS1 (lane 2) were analyzed on SDS-PAGE, and stained with Coomassie brilliant blue. 
Lane 3, 2 µg of bovine serum albumin (BSA), lane 4, a protein ladder. (B) B19V NS1 
specifically binds B19V Ori in vitro. γ-ATP labeled B19V Ori (lanes 1-7) or Ori-mut (lanes 8 
and 9) was incubated with (lanes 2-6 and 9) or without B19V NS1 (lanes 1 and 8) in the binding 
buffer with 2 µg/ml poly[d(I-C)]. Cold Ori probe at ratios of 20 times (lane 3) and 200 times (lane 
4) or cold Ori-mut probe at levels of 20 times (lane 5) and 200 times (lane 6) was added for 
competition. Free and shifted probes are indicated. GST protein was added as a negative 
control (lane 7). (C) HBoV1 NS1 did not bind HBoV1 OriR in vitro. γ-ATP labeled HBoV1 
OriR was incubated with (lane 2-8) or without (lane1) HBoV1 NS1 in the binding buffer with 2 
µg/ml poly[d(I-C)]. Cold OriR and OriR-mut probes at 10 times (lanes 3 and 6), 100 times (lanes 
4 and 7), and 1,000 times (lanes 5 and 8) were included for competition. Free and shifted 
probes are indicated. (D) Non-specific HBoV1 NS1 binding to OriR. γ-ATP labeled HBoV1 Ori 
was incubated with (lanes 2-8) or without (lane1) HBoV1 NS1 in the absence of poly[d(I-C)]. 
Cold OriR/OriR-mut probe at 50 times (lanes 3 and 6), 10 times (lanes 4 and 7), 4 times (lanes 








Figure 3-11. HBoV1 NS1 alone or with NP1 did not specifically bind OriR in a pull-down 
assay.  
(A&B) Detection of B19V NS1 and B19V Ori binding. (A) Nuclear extract (NE) 
prepared from OptiB19VNS1-transfected HEK 293 cells were used to incubate with Biotin-
labeled B19V Ori (Bio-Ori, lanes 3-5) and B19V Ori-mut (lane 6), followed with streptavidin-
conjugated beads. Additionally, some reactions were additionally incubated with B19V Ori-mut 
at 30 times (lane 4) and B19V Ori at 30 times (lane 5). NS1 bands pulled down by the Bio-Ori 
are indicated. (B) The NS1 bands pulled down by Bio-Ori were quantified. Relative levels to the 
NS1 in lane 4 are shown with averages and standard deviations from three independent 
experiments. (C&D) Detection of HBoV1 NS1 and HBoV1 OriR binding. (C) NE prepared 
from OptiHBoV1NS1-transfected HEK 293 cells were used to incubate with HBoV1 OriR (lane 
2), and HBoV1 OriR-mut (lane 3), followed with streptavidin-conjugated beads. NS1 detected in 
the input is indicated. (D) NE prepared from OptiHBoV1NS1- and OptiHBoV1NP1-co-
transfected HEK293 cells were used to incubate with HBoV1 OriR or OriR-mut, followed with 







3-11B). As a control, non-biotin-labeled B19V Ori did not pull down any B19V NS1 (Fig. 3-11A, 
lane 2, and Fig. 3-11B), and Bio-Ori-mut only pulled down a few minor amount of NS1 (Fig. 3-
11A, lane 6, and Fig. 3-11B). By contrast, HBoV1 NS1 was not pulled down by either 
biotinylated Ori or Ori-mut (Fig. 3-11C, lanes 2&3), despite high-level expression of NS1 (Fig. 3-
11C, lane 1). As NP1 co-localized with BrdU labeled viral replication centers (Fig. 3-5), we 
tested the hypothesis that NP1 is critical for NS1 binding with OriR. We prepared nuclear 
extracts from cells co-expressing NP1 and NS1, and performed pull-down assays. The results 
demonstrated that biotinylated HBoV1 OriR did not pull down NS1, even in the presence of NP1 
(Fig. 3-11D, lane 2). Collectively, the pull-down assays suggest that HBoV1 NS1 does not bind 
HBoV1 OriR in vitro in the presence of cellular factors and NP1. 
  
 Discussion  
In this report, we studied the viral components of both in cis and trans that are required 
for HBoV1 terminal resolution at REH. We defined a 46-nt sequence at nt 5,357-5,402 as the 
HBoV1 OriR. It contains both the NSBEs and nicking site, and is used as a template for HBoV1 
DNA replication at REH. Notably, a cis sequence in the 3’ NCR was critical for viral DNA 
replication at the OriR, while the large NS protein NS1 and the small NP1 played a pivotal role 
in trans for viral DNA replication at the OriR. These basic findings of HBoV1 DNA replication at 
the OriR lay a foundation for further understanding the mechanism underlying NS1 binding to 
and nicking at the OriR, which are the key steps in HBoV1 RF DNA replication. Additionally, in 
this study, we show, for the first time, the specific binding of the B19V NS1 with B19V Ori in 
vitro.    
  
Functions of viral proteins in HBoV1 DNA replication at OriR.  
NS1 function: The large non-structural protein of parvovirus, Rep78/68 or NS1, is 
composed of a putative DNA origin binding/endonuclease domain (OBD), helicase activity 
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domain, and transactivation domain (TAD) at N-terminus, middle, C-terminus, respectively 
(134). We have previously resolved the crystal structure of the HBoV1 OBD at 2.7-Å resolution, 
which is similar to the canonical histidine-hydrophobic-histidine superfamily of nucleases. The 
OBD structure combines two distinct functions: (i) a positively charged region formed by surface 
β-hairpin (aa190-198) and helix α5 (aa127-132), which is responsible for recognizing the viral 
DNA replication origin, and (ii) the endonuclease active site which contains signature motif HUH 
and performs strand-specific cleavage at Ori (152). The HUH motif of HBoV1 OBD contains two 
histidine residues (H115/H117) separated by cysteine C116, followed by the three hydrophobic 
residues I118, L119, and V120 (152). However, these active sites are only predicted from 
superposition of the HBoV1 OBD structure into the AAV5 OBD structure (72). Here, we 
confirmed that R193 and R194 in the surface hairpin of the OBD and K127 and R128 in the loop 
region are critical to terminal resolution, and, by contrast, the neighboring 123EGL125 residues 
are not. Mutation of the two histidine residues (H115 and H117) confirmed their nicking function. 
Structure study of the MVM NS1 OBD also revealed conserved residues of DNA binding and 
nicking activities (150), highlighting the importance of the confirmed DNA binding and nicking 
residues of the HBoV1 NS1 OBD.   
NP1 function: We have previously shown that bocaparvovirus NP1 plays an important 
role in the replication of viral duplex DNA (69,145). HBoV1 NP1 or BPV1 NP1 can complement 
replication of a mutant MVC infectious clone that does not express MVC NP1 (145). Three other 
newly identified HBoV1 small NS proteins NS2-4 are not required for replication of HBoV1 
duplex DNA genome in HEK293 cells (134). Since NS2-4 all contain the NS1C terminus, the 
anti-NS1C antibody reacts with all these isoforms (134). Thus, we demonstrated that all NS1-4 
proteins and NP1 colocalize within APAR bodies. Nevertheless, it is unlikely that NS2-4 recruit 
NP1 to the APAR bodies. Direct interactions between NS1-4 and NP1 were not confirmed (Fig. 
3-6). NP1 contains a non-classical nuclear localization signal (ncNLS) at aa7-50 (92), and is 
able to complement the functions of the MVM NS2 in viral DNA replication during an early 
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phase of infection (106). In fact, during MVM infection of NP1-expressing A9 cells, NP1 was 
progressively lost from its nucleolus-localization and began to be colocalized with MVM NS1 in 
APAR bodies. Moreover, NP1 expression rescues APAR body maturation in cells infected with 
an NS2null mutant of MVMp (106). Additionally, NP1 is involved in viral pre-mRNA processing 
(53,143,173). HBoV1 NP1 is required for viral mRNA splicing at the A3 splice site and read-
through of the viral mRNA through the (pA)p site (173). Taken together, we hypothesize that 
during infection or viral DNA replication, NP1 is critical in the development of viral DNA 
replication centers (APAR bodies) together with NS1, in which cellular DNA replication factors 
are enriched, however, after the formation of the APAR bodies, NP1 could be relocated to the 
cellular compartment for viral RNA processing. On the other hand, NP1 could possibly be 
recruited by cellular DNA replication factors to the APAR bodies, in response to the efforts of 
NS1 in interacting with the viral Ori and cellular DNA replication factors (29,71,112).    
 
Identification of the HBoV1 OriR. 
For a homotelomeric parvovirus whose replication depends on a helper virus, a 43-nt 
DNA sequence, was identified as the AAV Ori, containing the Rep binding element (RBE) and 
nicking site (128). For homotelomeric parvoviruses that replicate autonomously, a specific 38-nt 
DNA sequence has been identified as the Ori of goose parvovirus (GPV) (135), and a 67-nt 
DNA was identified as B19V Ori that contains a nicking site and four GC-rich NSBEs that are 
required for optimal virus replication (63). The B19V ITR resembles that of GPV in that both 
have an arrow-like hairpin structure (36,170). For heterotelomeric parvoviruses that replicate 
autonomously, there are two replication origins located at the LEH and REH, respectively. The 
active form of MVM LEH Ori (OriLTC) is ~50-nt in length, composed of a transcription factor PIF 
binding site, the (ACCA)2 NSBEs, and the nicking site (33,35). It functions as a template for 
junction resolution that generates ssDNA genome. By contrast, the MVM REH Ori (OriR) is 
around 125-nt in length, and contains a region composed a nicking site and two closely 
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contacted (ACCA)2 NSBEs, a degenerate NSBE (CGGT) at the tip of the hairpin, and a cis 
sequence that is non-specifically bound by HMG1/2 family DNA binding proteins (30). 
Therefore, the MVM OriR includes almost the entire sequence of the REH (30,35). 
In this study, we identified a 46-nt sequence (OriR) at the REH of the HBoV1 genome is 
responsible for the replication of duplex HBoV1 genome in HEK293 cells. This OriR represents 
the first Ori in members of heterotelomeric parvoviruses that functions as a template of terminal 
resolution in a short closely contacted DNA sequence (46-nt), containing the NSBEs and nicking 
site. We speculate that cis-acting sequences surrounding the nicking site and NSBEs are 
required for interacting with cellular factors, e.g., HMG1/2 with MVM OriR (30) and PIF with 
MVM OriL (26).            
 
Characterization of the nicking site and NSBEs.   
The nicking site at which Rep78/68 or NS1 nicks is specific to each parvovirus (36). The 
nicking site (5’-GAGT/TGG-3’) is conserved only in AAV1-4 and 6, but AAV5 uses 5’-
AGTG/TGGC-3’ (19). For autonomous parvoviruses, GPV uses (5’TGAG/TCT3’) (135), B19V 
Ori uses a unique nicking site (5’-GACA/CCA-3’) (63), and MVM uses a nicking site (5’-
CTWW/TCA-3’, W=A/T) (135). Thus, the nicking sites of autonomous parvoviruses differ from 
each other. The HBoV1 nicking site (5’-CTA/TATCT-3’) identified in this study closely resembles 
the MVM TRS with an A/T-rich sequence in the center. Of note, such a similar nicking site is not 
found at the LEH of the HBoV1 genome, therefore. However, one unique nicking site of AAV2 
Rep78/68 (5’-CTCCA/TTT-3’) has been identified in the minimal replication origin present within 
the AAV2 P5 promoter (56,163). The nicking of the AAV2 Rep78/68 at the nicking site in the P5 
promoter involves the TATA box in cis and the TATA-binding protein in trans (56). We 
hypothesize that HBoV1 NS1 must employ a different nicking site to perform junction resolution 
at the OriL of the LEH, and that cellular transcriptional factors or DNA binding proteins should 
facilitate nicking of the NS1 at the nicking site at the OriL. 
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 Several Rep78/68 and NS1 binding elements have been characterized, and confirmed 
by in vitro binding assay. The AAV RBE consists of three tetramer repeats (GCTC)3 plus a 
degenerate GCGC (128). Similar three tetramer repeats (GTTC)3 plus GAAC were found in the 
ITR of GPV (135). Two hexamer repeats (GCCGCCGG)2 were confirmed to bind B19V NS1 
OBD in an in vitro binding assay (151). MVM NSBE in either the OriL or OriR, comprise 2-3 
tandem copies of the tetranucleotide (TGGT)2-3. Densoparvovirus GmDNV NS1 binds a (GAC)4 
trimer repeated sequence in its ITR (153). A consensus NSBE for HBoV1 NS1 binding cannot 
be found in the LEH and REH of HBoV1 genome (69). In the HBoV1 OriR identified in this 
study, at ~12 nt downstream of the nicking site, a tetramer tri-nucleotide [(TGT)4] was proved 
critical to viral duplex DNA replication at the OriR. However, we were not able to confirm a 
specific binding between HBoV1 NS1 and OriR in vitro. We believe that our in vitro binding 
assay is capable of revealing the specific binding. We adapted the in vitro binding buffer which 
has been successfully used to confirm MVM NS1 binding to its NSBE (24,29). We also 
demonstrate B19V NS1 binding to the B19V Ori in side-by-side studies assessing HBoV1 NS1 
binding of the HBoV1 OriR. Although a strong and specific binding between B19V NS1 and its 
Ori was observed and confirmed, we did not observe any specific binding between HBoV1 NS1 
and OriR. We had further used a more sensitive in vitro binding assay, in which an anti-NS1 
antibody was used to pull down any bound OriR (29), to observe the interaction between NS1 
and OriR. Again, we did not observe any positive binding (data not shown). Therefore, we 
speculate that HBoV1 NS1 and OriR binding may require the involvement of viral and cellular 
proteins. However, in a subsequent in vitro pull-down assay, the biotinylated HBoV1 OriR did 
not pull down any HBoV1 NS1 from the lysate of the cells expressing HBoV1 NS1. As a control, 
B19V Ori pulled down NS1 at a significantly higher level than the mutant Ori, which can be 
competed by the wild–type B19V Ori but not the mutant Ori. A further experiment using nuclear 
extract prepared from NS1- and NP1-coexpressing cells also did not show any binding between 
HBoV1 NS1 and OriR. We hypothesize that in vivo oligomerization of the NS1 may be 
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necessary to the recognition of the NSBEs, as Rep78 is oligomerized in recognition the RBEs 
(67).                       
Nevertheless, based on the model of rolling circle replication in which Rep78/68 or NS1 
has to bind the origin and melt the duplex viral DNA, and performs nicking of the ssDNA at the 
nicking site of ~20-nt upstream of the NSBEs (35), we believe that the (TGT)4 repeat in HBoV1 
OriR should be the NSBEs. The (TGT)4 repeat closely resembles the (GAC)4 repeat of GmDNV 
NSBE (153). Since the (TGT)4 repeat contains the (TGTT)2 repeat, the HBoV1 NSBEs also 
resemble MVM NSBEs (TGGT)2-3 (29). Considering no cognate binding sequence can be found 
in the origins at both the LEH and REH of HBoV1 genome, we hypothesize that contrary to what 
has been observed, HBoV1 NS1 must bind the origins at a low affinity and requires the help of 
other viral components and cellular proteins to do so.   
 
Function of the 3’ NCR of HBoV1. 
Identification of a role of the 3’ NCR between VP-coding region and the REH in HBoV1 
DNA replication is important. In other parvoviruses, various cis-sequences that are outside of 
the terminal hairpins have been identified to be important for DNA replication, e.g., an additional 
AAV2 minimal DNA replication origin at the P5 promoter (5’ NCR) (115,156,163). In MVM, it has 
been shown that specific elements inboard of the REH between nt 4,489-4,636 and nt 4,636-
4,695 are necessary for efficient replication of MVM duplex DNA (146). In the development of 
recombinant MVMp vector (rMVMp), the rMVMp genome, a large portion of cis-element was 
remained at the 3’ end (nt 4,631-5,149) (65). However, how these cis-elements outside of the 
hairpins facilitate viral DNA replication has not been studied.      
 We have previously developed a recombinant HBoV1 vector, in which both the rAAV2 
genome and rHBoV1 genome were used. However, large portions were retained at the 3’ and 5’ 
end in the rHBoV1 genome, in order to ensure efficient replication in the presence of a 
packaging plasmid (168). Unfortunately, the cis-sequences that remained resulted in a high rate 
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of recombination that generated wild-type virus in the rHBoV1 preparations (168). Therefore, to 
define the cis minimal requirement for HBoV1 DNA replication is important to develop a better 
rHBoV1 vector that may hold benefits for gene targeting in human airways, since 95% of the 
HBoV1 genome is negative sense, while the AAV genome has equal polarity (10,145). We plan 
to further define the cis element at the left end in order to construct an rHBoV1 genome that has 







Chapter IV:  
Hairpin-independent HBoV1 DNA replication   
 
Abstract 
Parvoviruses are ssDNA viruses with duplex hairpin structures at the ends. The hairpin 
sequences on both ends are indispensable to viral DNA replication. Here we provide evidence 
that the duplex genome of human bocavirus 1(HBoV) replicates in HEK293 cells independent 
on the hairpin structure. We propose a model of HBoV1 DNA replication in that the large 
nonstructural protein NS1 may guide the direction of the strand-displacement, which is 
previously called “hairpin-transfer” step in parvovirus DNA replication. Thus, our study extends 
our understanding of parvovirus DNA replication in general.  
 
Introduction 
Parvovirus has a single stranded DNA (ssDNA) genome. Both termini of the genome 
harbor partially inverted repeat sequences, which are predicted to be hairpin structure. A 
‘rolling-hairpin model’ of parvoviral DNA replication has been proposed, which was essentially 
derived from the ‘rolling-circle replication model’ utilized by bacterial phages (148). Based on the 
hairpin structures, parvoviruses can be categorized into two groups: homotelomeric 
parvoviruses that contain inverted terminal repeats (identical repeats at both termini), and 
heterotelomeric parvoviruses that has disparity terminal sequences and structures at ends. All 
the dependoparvovirus are homotelomeric, including adeno-associated viruses (AAVs). Most of 
the autonomous parvoviruses, which replicate in cells independent of a helper virus, belongs to 
heterotelomeric parvoviruses, except for members of the genera Erythroparvovirus and 
Dependoparvovirus. For autonomous parvoviruses, the viral DNA replication mechanism has 
been largely studied for protoparvoviruses, e.g., minute virus of mice (MVM). To be notified, as 
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most of the heterotelomeric virus genome isolated are negative in sense, the left-end hairpin 
(LEH) is designated to be at 3’ end, while the right-end hairpin (REH) at 5’ end.  
Human bocavirus1 (HBoV1) is a human pathogen identified in 2005 (1). It associates 
with lower respiratory tract infections worldwide, especially to infants under 2 years old 
(2,13,23,50,59,61,73,74,104,105,111,132). Death cases were also reported due to high virus 
loads (23,85,158). HBoV1 belongs to genus Bocaparvovirus of the Parvoviridae family. It infects 
and replicates the well-differentiated human airway epithelial cells but not the highly dividing 
cells (41). Although HBoV1 does not infect HEK293 cells, the HBoV1 duplex genome replicates 
in HEK293 cells (69). The HBoV1 genome structure is quite unique, compared with other 
parvoviruses. It is heterotrimeric, but the REH is a perfect palindromic hairpin (69).  
Other representative members of bocaparvoviruses are minute virus of canines (MVC) 
and bovine parvovirus 1 (BPV1) (145). Although they were isolated decades ago, little is known 
about the DNA replication of bocaparvoviruses. Moreover, HBoV1 has been explored to 
produce recombinant HBoV1 vector that packages rHBoV1 genome, which has been shown 
promising in the application of gene delivery in human airway (168).  
In this study, we attempted to examine the replication model of bocaparvovirus using the 
HBoV1 reverse genetics system in HEK293 cells. We observed novel replication patterns of 
HBoV1 genome, whose replication is independent of the hairpin structures at ends. We 
confirmed this fact by using different approaches, and proposed a potential HBoV1 DNA 
replication model. This study not only improves our understanding of parvovirus DNA replication 
in general, but also helps to develop better strategies to generate rHBoV1 vector in HEK239 
cells.  
Material and Methods 
Plasmids construction.  
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pIHBoV1, pHBoV1Ori, pHBoVΔREH2 were previously described. pHBoV1OriRλm1 were 
constructed by inserting Lambda (λ) DNA sequences of 250 bp (nt 10,030-10,280) immediately 
after the Ori in pHBoV1Ori. Similarly, λ DNA sequences of 500, 750, 1000, 1500 bp were 
inserted just after the Ori in pHBoV1-Ori to construct pHBoV1OriRλm2, pHBoV1OriRλm3, 
pHBoV1OriRλm4, and pHBoV1OriRλm5. In addition, λ DNA sequences of 500 bp (nt 10,030-
10,530) and 1,000 bb (nt 10,030-11,030) were introduced at the 5’ end (nt 141) of the HBoV1 
sequence in pHBoV1Ori to construct pHBoV1OriLλm1 and pHBoV1OriLλm2.     
Cell culture, transfection, and virus infection.  
HEK 293 cells were cultured in HyClone™ Dulbecco’s Modified Eagle Medium (DMEM, 
GE Healthcare Bio-Sciences, Piscataway, NJ) with 10% fetal calf serum (FCS, #F0926, Sigma-
Aldrich, St Louis, MO). HEK293 cells grown in 60-mm dishes were transfected with 3 µg of 
plasmid as indicated in the figures, LipoD293 transfection reagent (SignaGen, Rockville, MD) 
was used following manufacturer’s instructions. HAE-ALI cultures were generated following 
previously publications (69,134). HAE-ALI cultures were infected with HBoV1 at an MOI=10 
from the apical side of the ALI culture.  
Low-molecular-weight (Hirt) DNA extraction and Southern blotting.  
Hirt DNA extraction and Southern blotting were performed exactly as previously 
described (134). After hybridization, the membrane was exposed to a phosphor screen, which 
was finally scanned on a phosphor imager (GE Typhoon FLA 9000, Fuji). The developed image 
was processed analyzed using ImageQuant TL8.1 software (GE healthcare, Marlborough, MA). 
Two-dimensional (2D) gel electrophoresis (57,94,113).  
Hirt DNA samples were extracted and digested by DpnI as described in Southern 
blotting (134). The treated samples (~ 500 ng) were first loaded onto the first dimensional gel of 
0.7 % agarose gel (prepared in TAE buffer) with a molecular size marker ranged from 3-20 kb, 
supplemented with 10 ng/ml ethidium bromide, and were electrophoresed for 36 hr at 15 volts. 
Then, the sample lane was excised out of the gel and was rotated 90° before heading to the 
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edge of the second dimension gel. The excision edge was fused with the second dimension gel 
by heated 0.7% agarose. The second dimension gel was prepared of 1% agarose in deionized 
water. After forming firm fusion, the fused gel was emerged in alkaline running buffer (30 mM 
NaOH, 2 mM EDTA) for an hour before electrophoresis. The second dimension gel was run for 
24 hr at 20 volts. Then, the alkaline buffer was exchanged by deionized water and washed three 
times (each for an hour) with slightly shaking. The following steps were performed the same as 
those in Southern blotting, including buffer exchanging, membrane transferring, hybridization 
and signal exposure. 
Result 
HBoV1 duplex genome replicates in HEK293 cells without hairpin structures. 
Previously, we identified the minimal replication origin (OriR) at the REH of HBoV1 
genome. This is a 46-nt sequence, including NS1 binding and nicking sites. OriR replicates 
independent of the LEH in the context of NS1 and NP1 gene expression. Notably, OriR does not 
harbor hairpined sequence within itself. To further confirm replication of the OriR independent of 
any hairpin sequence, we constructed various mutants by extending OriR with different length of 
non-specific λ DNA sequence. In the context of pHBoVOri, 0.25, 0.5, 0.75, 1, or 1.5 kb λ DNA 
were added beyond of the right end of the OriR (Fig. 4-1A). Constructs with 0.5 or 1kb λ DNA 
inserted at the left end of genome in the context of pHBoV1Ori were made as controls. We 
transfected linearized DNA of the constructs and performed Southern blotting to examine viral 
DNA replication. We observed that OriR still replicated with non-specific DNA inserted into 
either the left end (Fig. 4-1B, lane 1, 2) or the right end (Fig. 4-1B, lane 3-7) of the duplex DNA 
of the HBoV1OriR. The increased size of the replicative DNA (RF DNA) represented the length 
of the DNA fragments with an extended sequence (insertion). 
  
Resolution of the replicative intermediates by 2-dimentinal gel electrophoresis. 
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Figure 4-1. HBoV1-Ori replicated with extended non-specific sequence on either of the 
terminals.  
(A) Diagram of HBoV1Ori and its mutants with various λ phage sequence 
insertions. Based on the HBoV1Ori, 0.25, 0.5, 0.75, 1, or 1.5 kb of λ DNA sequence was 
inserted at the right end of HBoV1 sequence (OriR). In comparison, 0.5 or 1 kb of λ DNA 
sequence was inserted at the left-end of HBoV1 sequence (in which the REH was already 
deleted). (B) Southern blot analysis of HBoV1Ori mutants with λ sequence insertion. 
Linearized constructs as indicated were transfected into HEK293 cells. 2 days post transfection, 







Two possible mechanisms could explain how the viral DNA is synthesized without the 
hairpin ends. One possibility is that a free molecule attached at the 3’ end of the viral DNA,  
which acts as a primer and providing free 3’–OH for the second strand DNA synthesis. Another 
possibility is that the 3’ end of the viral DNA could be turn around by itself to form a hairpin 
structure even without a sequence that has complementary nucleotides.  
To explore which strategy is utilized during the replication of the OriR, we used 2-D gel 
electrophoresis to analyze small molecular weight (Hirt) DNA extracted during OriR replication 
of HBoV1Ori-transfected HEK293 cells. In 2-D gel electrophoresis, vertical dimension separates 
DNA by sizes, while the horizontal dimension differentiates DNA by structure, so that the DNA 
molecules with the same size but in different structure will be revealed on the 2D. Previously, 
we constructed ΔREH2 based on pHBoV1 (LEH-VP1/3-), whose replication level is comparable 
with that from the infectious clone pIHBoV1 in HEK293 cells. ΔREH2 does not hold any hairpin 
sequences at the ends. By 2-D gel electrophoresis, ΔREH2 replication revealed 4 dominant 
replication intermediates (Fig. 4-2B). Dot A and Dot B are closed monomer replicative form (c-
mRF) and opened monomer replicative form (o-mRF), respectively. Dot C and Dot D are 
obviously dimeric size of closed and open replication form (c-dRF & o-dRF), respectively. Single 
stranded DNA could derived from either strand displacement (very minor) or the product of 
nicking dRF DNA (dot E). The appearance of Dot A and Dot C proved hairpin (or turn-round) 
structure is formed during replication of ΔREH2. More importantly, replication of HBoV1Ori or 
HBoV1Ori-0.25kλ showed a highly accumulated Dot A (Fig. 4-2, C&D), suggesting that the 
hairpin (or turn-round) structure is formed during the replication of these hairpin-less HBoV1 
DNA. 
To supplement the ‘rolling hairpin replication model’ derived from the study of MVM, we 
proposed the HBoV1 DNA replication model independent of hairpin sequence, based on the 
above observations (Fig. 4-2). After NS1 nicking at OriR and DNA synthesizing to the end of the 
right terminus (Fig. 4-3, Steps 1-2), the newly synthesized 3’ end turns around towards itself.  
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Figure 4-2. HBoV1 Ori replicates independent of hairpin structure at the right-end, which 
still reveals hairpin structure (turn-around) replicative intermediates.    
(A) Diagram of putative replicative intermediates on a 2-D gel. The vertical 
dimension is a low concentration agarose gel electrophoresed at a low voltage. Based on 
molecular weight, ssDNA, RF DNA and dRF DNA are separated as indicated. Transferring 
clockwise for 90 ºC, the second dimension is a high concentration agarose gel electrophoresed 
in an alkaline buffer. Covalently linked duplex from intermediates (c-mRF and c-dRF DNA) are 
separated with open ended duplex (o-mRF, o-dRF) as indicated. Single stranded DNA (ssDNA) 
is either nicked from c-dRF DNA or derived from strand displacement as indicated. (B-D) 2-D 
gel electrophoresis analysis of DNA replication. The lower MW DNA samples extracted from 
HEK293 cells transfected with HBoV1ΔREH2 (A), HBoV1Ori (B), and HBoV1Ori-Rλm1 (C) were 







Figure 4-3. Proposed model of hairpin sequence-independent HBoV1 DNA replication.  
Similar as the hairpin-transfer model, NS1 binds to a duplex DNA sequence harboring 
an Ori. With potential cellular factors involved, NS1 binds Ori at the NS1-binding site, and nicks 
the top strand (5’ to 3’) of the Ori at the nicking site upstream of the NS1-binidng site, and 
covalently linked to 5’ end of the nicked strand. In the second step, NS1 in combination with 
cellular replication machinery extend the free 3’ nicked site to end of the genome. In the 
following, NS1 unwinds the end duplex by the helicase activity meanwhile helping 3’ free-OH 
folded back to match somewhere within the same molecule. NP1 and other cellular components 
may directly involve in this step. Further DNA synthesis and strand displacement processes with 
the cellular DNA replication machinery, and the bottom strand is replaced with newly 
synthesized DNA. The product is the right-end closed DNA in the length of a monomer 
replicative form (c-mRF). In the same manner, the NS1 and related factors could refold and 
base-match the 3’ end to the inboard DNA within itself, initiating the second round of strand 
displacement. The product will be the left-end closed DNA in length of double replicative form 
(c-dRF). Intermediates such as RF DNA and dRF DNA could be resolved by terminal resolution 
(Step 7’, 9), resulting in open RF DNA or dRF DNA (o-mRF, o-dRF). The corresponding 








We hypothesize that NS1 protein is involved in the self-turning-round process with potential help 
from cellular factors (Fig. 4-3, Step 3). Similarly, the replication folk could fold back the 3’ end of 
mRF to further the strand-displacement to produce dRF DNA (Fig. 4-3, step 6). Different from 
the MVM replication model, tetrameric DNA replicative form (tRF DNA) was not obviously 
detected during HBoV1 DNA replication (Fig. 4-3, step 9), suggesting that viral ssDNA genome 
could be directly resolved from dRF DNA.   
 
2-D gel electrophoresis analysis of DNA replication of full-length duplex HBoV1 DNA and 
during virus infection.   
To further look into the replication of the viral DNA that has hairpin sutures, we resolved 
the replication intermediates from pIHBoV1-transfected HEK293 cells by 2-D gel electrophoresis 
(Fig. 4-4A). We observed that, besides the four dots accumulated in the ΔREH2-transfected 
sample, 3 additional dots appeared around Dot A (c-mRF) and two additional dots around Dot C 
(c-dRF) (Fig. 4-4A). Comparing with ΔREH2, pIHBoV1 has the LEH sequence. Those new dots 
may reflect the replicative intermediates from resolution of the Ori at the LEH. Moreover, we 
resolved the replicative intermediates during HBoV1 infection of HAE cells. Surprisingly, the 
replication pattern of virus-infection of HAE cells didn’t reveal apparent accumulations of dRF 
DNAs (Fig. 4-4, B). Similarly to the transfection with duplex HBoV1 genome and its mutants, 
HBoV1 infection accumulated largely the c-mRF (Dot A) and o-mRF (Dot B) intermediates, 
except for a dominant accumulation of ssDNA. The shortage of dRF and accumulation of 
ssDNA strongly suggests that either in transfection of the duplex HBoV1 genome or during virus 
infection, dRF DNA is generating rapidly and therefore becomes a transient step that is a 
template to generate ssDNA genome, or the (junction) resolution process from RF DNA to 




Figure 4-4. Analysis of replication of the full-length HBoV1 duplex genome and of HBoV1 
infection using 2-D gel electrophoresis. 
(A) 2-D gel analysis of transfection of HBoV1 infectious clone. pIHBoV1 was 
linearized and transfected into HEK293 cells. Hirt DNA extraction and 2-D gel analysis were 
performed as mentioned above. (B) 2-D gel analysis of HAE cells infected by HBoV1 virus. 
Well differentiated HAE cells cultured on air-liquid interface were infected with HBoV1 in a MOI 
of 10. Hirt DNA was extracted at 14 days post-infection and was subjected to 2-D gel 








The replication mechanism of autonomous parvovirus has been mainly studied in MVM.  
It is not clear whether other heterotelomeric parvoviruses take a similar strategy for replication. 
With the discovery of HBoV1 and many more other parvoviruses that are distinct from 
protoparvoviruses in hairpin sequence and structure (18,69,77). We believe that it is significant 
to understand how these viruses replicate, especially for these ones that cause diseases in 
humans, e.g., parvovirus B19 (B19V) and HBoV1.  
Previously, we observed a mutant B19V infectious clone, which has large deletions on 
ITRs and was excluded of the hairpin sequence, replicated in both HEK293 cells and B19V-
permisive cells, UT7/Epo-S1 cells (63). In the previous study of the identification of the HBoV1 
OriR, we defined the OriR to be a 46-nt sequence on the REH (134). In this study, we prove that 
HBoV1 DNAs only containing the OriR replicate in HEK 293 cells by turning round itself at end 
of the OriR. Further analysis of the replicative intermediates in transfection of duplex HBoV1 
genome and HBoV1 infection reveals that the monomer replicative form DNA is the dominant 
replicative intermediates of HBoV1 DNA replication. Thus, our study highlights a new model of 
autonomous parvovirus DNA replication in that NS1 plays a more important role in directing 
hairpin-switch and strand-displacement than the hairpin structure per se. HBoV1 may use a 
unique mechanism to carry out junction resolution that results in the production of ssDNA 
genome, awaiting further investigation.              





Chapter IV:  
Conclusions  
The studies presented in this thesis for my PhD degree are composed of three parts. For 
the first part, we proved by different approaches that the transcription and expression profile of 
HBoV1 is much more complex than its sibling viruses in the genus Bocaparvovirus, especially, 
during infection. In this study, not only the expression of NS2, NS3, NS4 and NS1-70 was 
confirmed but also NS2 or NS3 related proteins were largely expressed during infection. As the 
HBoV1 is the only reported parvovirus that infects well-differentiated/non-proliferating cells, 
those novel proteins may help HBoV1 to replicate in this unique cell type. For the second part, 
we disclosed many details underlying the basic HBoV1 DNA replication mechanism. Thus, this 
study facilitates the understanding of HBoV pathogenesis and further development of antiviral 
strategies to combat HBoV1-associated diseases. For the third part, we promoted a new 
bocavirus replication model, which may also fit the replication mechanism of parvoviruses in 
other genera. These following points are derived from these studies. 
Functions of HBoV1 small NS proteins. Firstly, it is clear that NS2 protein is 
significant, as knocking out NS2 prevented airway epithelial cells from cilia loss and tight 
junction disruption caused by HBoV1 infection. Secondly, NS2-4 ORFs locate wholly within the 
ORF of NS1, and are expressed in redundant forms, like the NS2 or NS3-related proteins (Fig. 
2-8C). The virus replication and production is more disrupted if all NS-related proteins are 
knocked out. Last but not least, the cultured airway epithelial cells do not fully reflect the 
immune cellular networking in human airways. An HBoV1 infection animal model is needed for 
further study on the virus and its host interaction.        
HBoV1 pre-mRNA processing: Importantly, alignment of all 4 HBoV sequences 
showed that all splicing sites are reserved, including the newly confirmed D1’ and A1’ sites (Fig. 
1-2). Moreover, the new RNA splicing donor site in minute virus of canines (MVC) was identified 
and MVC NS2 expression was confirmed. In bovine parvovirus, there was also viral mRNAs 
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detected on Northern blot but without known origin (119). From an evolutionary perspective, 
those splicing sites may be conserved in bocaviruses. As HBoV is a new virus and evolved 
quite recently, It is also possible that those small NS proteins were highly expressed by the virus 
in adapting to the host (non-dividing cells) (78).  
Function of viral non-coding sequences: Alignment of the REH among HBoV1, BPV 
and MVC showed several conserved sequences, suggesting these sequences may bind the 
same cellular factors that facilitate viral DNA replication. In addition, the (pA)d signal of both 
BPV and MVC locates within the REH, whereas HBoV1 has it (pA) signal located in the VP1-
coding sequence. Therefore, HBoV1 leaves a large space downstream of the REH, referred as 
3’ NCR. Together with the evidence that HBoV1 NS1 does not specifically bind OriR, it is 
suggested that viruses from the same genus are evolving quite uniquely, in order to adapt to 
their residing host, proliferating vs. non-proliferating (differentiated) cells.   
Notably, previous studies speculated the NS1 could only specifically bind to the 
replication as in dimer or oligomer forms (116,169). We essentially followed this protocol but still 
failed to detect any specific HBoV1 NS1-OriR binding (Figure or data not shown). Considering 
the importance of the 3’ NCR in HBoV1 DNA replication, it is possible that the 3’ NCR may 
function in the recognition of the NS1 with the OriR.  
Hairpin-independent DNA replication:  Similar to the observation with B19 replication, 
we proved that HBoV1 replicates independent on the hairpin structure at the REH in our study. 
Further results showed that even mature virions were produced from a pIHBoV1-based clone 
that has more than half of the REH truncated, although at a titer of 1-2 log decrease, compared 
with the wild type counterpart.  
The functions of NP1, small NS proteins and 3’ NCR in HBoV1 DNA replication need 
further investigation, and much information will be revealed on HBoV1 NS1 binding, NP1 
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